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Engineering the surface functionality of nanomaterials is the key to investigate the 
interactions between nanomaterials and biomolecules for potent biological applications 
such as therapy, imaging and diagnostics. My research has been orientted to engineer 
both of the surface monolayers and core materials to fabricate surface-functionalized 
nanomaterials through the synergistic multidisciplinary approach that combine organic 
chemistry, materials science and biology. This thesis illustrates the design and synthesis 
of the surface-funcitonalized quantum dots (QDs) and gold nanoparticles (AuNPs) for the 
fundamental studies and practical applications. For QDs, A new class of cationic QDs 
with quaternary ammonium derivatives was synthesized to provide permanent positive 
charge. The toxicity and stability of these cationic QDs were systematically investigated 
in cells. Furthermore, these cationic QDs were employed in the design of biosensor and 
fabrication of functional nanofibers. QDs with different surface functionalities were also 
used in the studies of controllable cellular uptake of nanoparticles and the construction of 
multifunctional nanocapsules. For AuNPs, cationic AuNPs were used to interact with 
proteins. The monolayer on AuNP surface can be tailored through host-guest chemistry to 
viii 
 
modulate the protein behaviors. Also, mass spectrometry was applied to detect the 
templation of AuNP monolayers to protein surface through molecular recognition. Taken 
together, nanomaterials with desired properties can be fabricated through surface 
functionalization approach to facilitate their use in biological system.  
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NANOPARTICLES IN BIOLOGICAL APPLICATIONS 
1.1 Introduction 
Nanoparticles (NPs) represent hybrid systems intermediate between small molecular 
systems and macroscopic materials. In these systems, the metal cores are of 1-100 
nanometer-scale and the surfaces are usually covered by a self-assembled monolayer of 
organic ligands. NPs exhibit a number of unique physical and chemical properties relative 
to bulk material. The novel properties of NPs arise from their enormous surface area, 
showing a dominance of the surface properties over bulk properties. The versatile and 
tunable properties of NPs are based on their component, size, shape, functionalized 
surface and chemical surroundings. Among various NPs, two most widely used NPs, 
quantum dots (QDs) and gold NPs (AuNPs), have attracted great interest in the scientific 
community and have been utilized in a broad range of biological applications, including 
biomolecular recognition, biological sensing, in vitro and in vivo imaging and drug/gene 
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and second is the solution-based methods in which QDs are grown in an organic solution 
and stabilized through coordinating ligands (Table 1.1). The solution-based methods are 
easy to follow, size and quantity is controllable, and the surface of QDs can be further 
functionalized with various ligands. Thus, most of the researchers prefer to use the 
solution-based methods to synthesize QDs.  
The breakthrough synthesis of high quality QDs in solution can be traced to the 
work from Murray et al.8 They reported the synthesis of high quality CdSe QDs by using 
dimethyl cadmium (Cd(CH3)2) as the cadmium precursor in the coordinating solvent at 
high temperatures. Most common coordinating solvents are trioctylphosphine oxide 
(TOPO), trioctylphosphine (TOP) and hexadecylamine (HDA), and these are usually 
used together. These solvents can be attached on the QD surface to prevent the 
aggregation of QDs and also determine the solubility of QDs in organic media. Peng and 
coworkers reported the synthesis of high-quality CdTe, CdSe and CdS QDs with CdO as 
cadmium precursor instead of Cd(CH3)2, which is very toxic, pyrophoric and unstable at 
room temperature.9 The size and the optical property of QDs are controllable by varying 
the concentration of precursors, ligand-to-precursor molar ratio, 10  capped ligand, 11 
number of precursor injections,12 growth temperature and growth time.13  
Table 1.1 Major types of QDs preparation methods 
QDs Precursor Capping ligand and condition Ref. 
CdSe Cd(CH3)2Cd, TBPSe TOP, TOPO, HDA, 250-300 oC 14 
 CdO, TBPSe TOPO, TPA/TDPA, 250-300 oC   9 
 Cd(AcO)2, TOPSe/TBPSe TOPO, SA, 200-320 oC 15 
 Cd(ClO4)2, NaHSe R-SH, pH~11.2, 100 oC 16 
 [CH3CdSe2CN(C2H5)2]2 TOP, TOPO, 250 oC 17 
CdS CdCl2, Na2S 2-mercaptoethanol (ME), RT 18 




CdTe CdO, Te HPA, HDA, TOP, 240-300 oC 20 
 CdO, TOPTe ODPA, TOPO, 300-330 oC 21 
ZnSe Zn(ClO4)2, Na2Se AOT 22 
 ZnCl2, H2Se GSH, 95 oC 23 
 ZnO, TOPSe LA, HDA, 280-300 oC 24 
PbSe PdO/OA, TOPSe OA, acetic acid or hexanoic acid, 
150-170 oC 
25 
*TOPO: trioctylphosphine oxide, TOP: trioctylphosphine, TOPSe: trioctylphosphine selenide, TBPSe: 
tributylphosphine selenide, ODPA: octa-decylphosphonic acid, TDPA: tetradecylphosphonic acid, SA: 
stearic acid, AOT: sodium dioctyl sulfosuccinate HDA: hexadecyl amine, HPA: hexyl-phosphonic acid, 
GSH: glutathione, OA: oleic acid, LA: lipoic acid 
Original QD core typically exhibits surface trapping states which act as fast non-
radiative de-excitation channels for photo-generated charge carriers. This process reduces 
the fluorescence quantum yield. The way to improve the surface passivation of QDs is 
the surface capping with a layer of semiconductor materials, resulting in core/shell 
structure. The shell provides protection against photo-oxidation, and also prevents surface 
quenching of excitons and aggregation of QDs, thereby quantum yield of fluorescence is 
also increased. 
According to the band gaps and the relative position of electronic energy levels of 
the involved semiconductors, the shell can have different functions in core/shell QDs. An 
overview of the band alignment of the bulk materials are shown in Figure 1.2a, and three 
cases of the denominated type-I, reverse type-I, and type- II band alignment are described 
in Figure 1.2b.26 The improvements and examples of the QDs with core/shell structure 
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on QDs have been designed toward the simultaneous detection of small molecules, 41 
toxins42 and nuclei acids.43 
1.3 Gold nanoparticles (AuNPs) 
Gold nanoparticles (AuNPs) have been widely employed in biology based on their unique 
properties and multiple surface functionalities. The ease of AuNP functionalization 
provides a versatile platform for nanobiological assemblies with oligonucleotides, 44 
antibodies, 45  and proteins. 46  Bioconjugates of AuNPs have also become promising 
candidates in the design of novel biomaterials for the investigation of biological 
systems.47 
1.3.1 Synthesis of AuNPs 
A wide array of solution based approaches has been developed for AuNP synthesis in the 
past few decades to control as the size,48  shape49 and surface functionality.50 Turkevich et 
al. developed a synthetic method for creating AuNPs in 1951 by treating hydrogen 
tetrachloroaurate (HAuCl4) with citric acid in boiling water, where the citrate acts as both 
reducing and stabilizing agent (Figure 1.6a).51  Frens further refined this method by 
changing the gold-to-citrate ratio to control particle size.52 This protocol has been widely 
employed to prepare dilute solutions of moderately stable spherical AuNPs with 
diameters of 10 to 20 nm, though larger AuNPs (e.g., 100 nm) can also be prepared. 
Nevertheless, these citrate-stabilized AuNPs can undergo irreversible aggregation during 
functionalization process with thiolate ligands.  Several strategies have been developed to 
conquer this problem including using a surfactant, Tween 20, prior to the modification to 
prevent aggregation (Figure 1.6a),53 or using thioctic acid as an intermediate via a two-
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1.3.2 Physical properties of AuNPs 
Spherical AuNPs possess useful attributes such as size- and shape-related optoelectronic 
properties,58 large surface-to-volume ratio, excellent biocompatibility and low toxicity.59 
These properties make AuNPs an important tool in bionanotechnology (Table 1.3).  
Important physical properties of AuNPs include surface plasmon resonance (SPR) and 
the ability to quench fluorescence. Spherical AuNPs exhibit a range of colors (e.g., 
brown, orange, red and purple) in aqueous solution as the core size increases from 1 to 
100 nm, and generally show a size-relative absorption peak from 500 to 550 nm.60  This 
absorption band arises from the collective oscillation of the conduction electrons due to 
the resonant excitation by the incident photons (Figure 1.7) which is called a “surface 
plasmon band”.61  However, this band is absent in both small nanoparticles (d < 2 nm) 
and the bulk materials. This phenomenon is influenced not only by size, but also by 
shape, solvent, surface ligand, core charge, temperature and is even sensitive to the 
proximity of other nanoparticles.62 The aggregation of nanoparticles results in significant 
red-shifting of SPR frequency, broadening of surface plasmon band and changing the 
solution color from red to blue due to the interparticle plasmon coupling.63  
The superb quenching ability of AuNPs to proximal fluorophores comes through 
the deactivation pathway based on the good overlap between the emission spectrum of 
excited fluorophores and the surface plasmon band of AuNPs. 64  This fluorescence 
resonance energy transfer (FRET) phenomenon is observed even in the presence of 1 nm 
AuNPs due to the fact that radiative and nonradiative decay rates of fluorescent 
molecules are both distinctly affected by the nanoparticles.65 AuNPs also can act as 
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1.4 Dissertation overview 
Tailoring the surface monolayers of nanomaterials to investigate the interactions between 
nanomaterials and biomolecules provides a promising approach for the creation of 
potential biological applications. Seen from a biomedical perspective, these surface-
functionalized nanomaterials incorporate the unique physicochemical properties of the 
nanomaterial core while the tailored monolayers also provide multiple specific or 
selective interactions with biomolecules. My research have employed a synergistic 
multidisciplinary approach to combine synthetic chemistry, materials science and biology 
to fabricate surface functionalized QDs and AuNPs for fundamental research and 
practical biomedical applications (Figure 1.9). In the following chapters, I am going to 
describe the detail of the design and synthesis of the surface-functionalized 
nanomaterials, and their use in the fabrications of sensor arrays, multifunctional 
supramolecular nanostructures and functional nanofibers. The nanoparticle-protein 
interaction was also investigated, including the use of nanoparticle to modulate the 
protein behaviors as well as the templation of nanoparticle monolayers to protein surface 





































































































































different anchoring groups to investigate the cytotoxicity of cationic QDs with different 
surface ligand structures. Our studies revealed that dithiol-functionalized QDs were 
substantially less toxic than monothiol-functionalized QDs. QD-induced cytotoxicity was 
systematically investigated via several determining factors, including the intracellular 
factors (i.e. cellular uptake and liberation of cadmium ions) and extracellular factor (i.e. 
cellular membrane damage). The results indicated that the lower coordination number of 
ligand can increase the ligand packing density and subsequently enhance the cytotoxicity 
of the functionalized QDs, with the acute toxicity primarily derived from membrane 
damage. 
Effective use of functionalized QDs for imaging and sensing in living cells and 
animals requires an accurate assessment of monolayer stability since the biogenic thiols 
can displace the thiolate-bound ligands from QD surface. In chapter 4, we developed a 
quantitative tool for measuring of QD monolayer stability in cells using a combination of 
inductively coupled plasma mass spectrometry (ICP-MS) and laser desorption/ionization 
mass spectrometry (LDI-MS). The total QD uptake amounts were measured using ICP-
MS. In parallel, a fraction of the same sample was analyzed by LDI-MS to determine the 
monolayer amounts remaining on the QD surface. Using this method, we found that 
monolayer stability decreased as QD particle size increased. The smallest QD (2.9 nm) 
showed excellent stability in cells for up to 24 h, while the largest QD (5.9 nm) lost ca. 
70% of its monolayer over the same 24 h. Moreover, 40% of the monothiolate-bound 
monolayer was lost while complete monolayer retention was observed with the dithiolate 
monolayer. These studies showed that proper choice of both particle size and monolayer 
structure is critical for live-cell imaging applications.  
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In chapter 5, we used the cationic NPs to generate NP-based sensor arrays to 
demonstrate rapid and efficient sensing of mammalian cell types and states. These arrays 
were comprised of cationic QDs and AuNPs that interact with negatively charged cell 
surfaces to generate distinguishable fluorescence responses based on cell surface 
signatures. The use of QDs as the recognition elements and signal transducers presented 
the potential for direct visualization of selective cell surface interactions. Notably, this 
sensor was unbiased, precluding the requirement of pre-knowledge of cell state 
biomarkers and thus providing a general approach for phenotypic profiling of cell states, 
with additional potential for imaging applications. 
In chapter 6, we presented the incorporation of multiple functional building 
blocks into a nanoparticle-stabilized capsule (NPSC)-based structure by means of diverse 
supramolecular interactions. The three types of building blocks (i.e. AuNPs, QDs and 
proteins) on the NPSC shell can incorporate their individual properties into the functional 
capabilities of the structure, increasing the versatility of the capsule structure. The 
resultant supramolecular nanocapsules were stable in physiological media and 
demonstrated their multifunctional properties in cellular studies, such as fluorescent 
monitoring of the stimuli-responsive payload release and co-delivery of hydrophilic and 
hydrophobic cargos.   
In chapter 7, we synthesized glucose-functionalized quantum dots (Glc-QDs) and 
used insulin and 2-deoxyglucose (2-DG) to modulate their cellular uptake in C2C12 
muscle cells. The cellular uptake of Glc-QDs can be modulated up to almost two-fold 
under insulin stimulation while be down-regulated in the presence of 2-DG. These results 
demonstrate the use of secondary regulators to control the cellular uptake of NPs through 
18 
 
membrane protein recognition in a specific and fine-tunable fashion. 
In chapter 8, we presented a facile approach to fabricate functional nanofibers 
through post-NP functionalization using dithiocarbamate (DTC) chemistry. In the NP-
nanofiber composites, amine-terminated nanofibers were activated in the presence of CS2 
to generate DTC groups on the nanofiber surface, allowing the immobilization of AuNPs 
and QDs. The resulting NP-nanofiber composites were characterized by electron 
microscopy and energy dispersive X-ray spectroscopy. Furthermore, the functional 
nanofibers presented antibacterial activity and fluorescence property with the effective 
coating of AuNPs and QDs, respectively. This post-NP functionalization approach is 
simple and reliable to provide a monolayer of NPs on nanofibers for different 
applications. 
In chapter 9, we utilized supramolecular host-guest chemistry to modulate the 
protein-NP interactions through hydrophilicity/phobicity control of the NP surface. 
AuNPs were functionalized with specific molecular recognition moieties that can be 
recognized by cucurbit[7]uril (CB[7]) receptors. The addition and removal of CB[7] on 
NP surface generated a tunable surface of AuNPs. The binding constants and binding 
stoichiometries of the protein-NP complexes were fine-tuned as different amounts of 
CB[7] were bound on NP surface. CB[7] acted as non-covalent regulator to effectively 
control protein-NP interactions in a specific and reversible fashion. 
In chapter 10, we report the templation of monolayers on AuNPs through protein 
surface recognition, and the monolayer rearrangement was monitored by LDI-MS. The 
results showed that the mixed-ligands on NP surface can be repositioned and templated 
through complementary electrostatic interactions with proteins. The extent of the 
19 
templated NP monolayers was increased with the long complexation time, low salt 
concentration and low temperature, indicating the monolayer templation can be fine-
tuned through the control of environmental factors. The mass spectrometric detection of 
monolayer reorganization on NP surface will facilitate the design of the templatable NP 
monolayers for specific protein surface recognition. 
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CHAPTER 2 
SYNTHESIS OF CATIONIC QUANTUM DOTS VIA A TWO-STEP LIGAND 
EXCHANGE PROCESS 
2.1 Introduction 
Semiconductor quantum dots (QDs) are important class of nanomaterials due to their 
inherent physical properties such as size/composition-tunable fluorescence emission, high 
fluorescence quantum yield, extended fluorescence lifetime and photostability.1 QDs can 
provide better sensitivity and stability for biological application than that of traditional 
organic dyes and protein-based fluorophores.2 The unique optical properties of QDs make 
them appealing for biomolecular interaction studies 3  and biomedical applications 
including sensing,4 labelling5 and intracellular imaging.6   
The essential prerequisite for biological applications of QDs is solubility and 
stability in water and biofluids. Common synthetic routes for QDs, however, generate 
particles capped with hydrophobic surface ligands such as trioctylphosphine oxide 
(TOPO) and trioctylphosphine (TOP). 7  Several strategies have been developed to 
solubilize QDs in aqueous medium, including encapsulation and ligand exchange. 8 
Hydrophilic ligands, featuring negative, positive and neutral termini have been used to 
displace the hydrophobic ligands on the QDs and provide solubility.9  
Positively charged QDs are of particular interest for biological applications, 
providing a complementary surface binding for negatively charged proteins10 and nuclei 
acids11  via electrostatic interactions. This supramolecular design enables applications 
including intracellular delivery and sensing.12 Additionally, positively charged QDs have 
higher stability at low pH13 and possess higher cellular permeability than uncharged and 
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anionic analogs.14  Several groups have generated cationic QDs by using the amine-
containing ligands or polymers, with either thiol capping or hydrophobic encapsulation.15 
However, amine-functionalized QDs have a limited useful pH range due to the 
protonation/deprotonation of amine groups as QDs tend to aggregate and precipitate upon 
deprotonation at higher pH. 16  This pH dependence complicates both synthesis and 
applications of these cationic particles. 
Despite the potential advantages of permanently cationic QDs, to our knowledge 
there have been no examples of particle of this sort reported to date. To provide QDs with 
a permanent positive charge featuring extended pH and biofluid stability profiles we have 
explored protocols for the synthesis of quaternary ammonium functionalized QDs. The 
surface properties, i.e. hydrophobicity and hydrophilicity, of these cationic QDs are 
tunable through choice of terminal head group. The cationic QDs were synthesized via a 
two-step ligand exchange reaction featuring conversion of hydrophobic QDs to 
amphiphilic QDs followed by creation of cationic QDs from amphiphilic QD 
intermediate. The subsequent change in ligand polarity is the key factor in providing 
solubility of the QDs. This process is highly efficient, providing an essentially 
quantitative yield of the cationic QDs from the hydrophobic precursor. These QDs feature 
high purity, pH stability, and dispersibility in biofluids including serum, making them 
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head group choice (Figure 2.1a). The general synthetic scheme for synthesizing dithiol 
cationic ligands is given in Figure 2.1c. 
 Red fluorescent CdSe/ZnS QDs (emission at 593 nm) were used to prepare the 
cationic QDs through a ligand exchange process. Our initial efforts to produce cationic 
QDs focused on direct functionalization of TOPO/TOP-capped QDs (TOPO/TOP-QDs). 
This process, however, provided a very low yield of QD (< 10%). To address this 
problem, we developed a two-step ligand exchange process. As showed in Figure 2.1b, 
the first step involves the phase transfer conversion of hydrophobic TOPO/TOP-QDs to 
amphiphilic HS-C5-TEG capped QDs using methanol as solvent. The particles were then 
purified, resuspended in methanol and the corresponding dithiol ligand added to provide 
hydrophilic DHLA-TEG-N(CH3)2-R capped QDs. These particles were quite clean; 
matrix assisted laser desorption/ionization mass spectrometry (MALDI-MS) analysis 
showed the complete removal of both the initial capping ligand (TOPO/TOP) and the 
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2.4 Experimental section 
All chemicals were purchased from Aldrich unless otherwise stated. The organic solvents 
were bought from Pharmco-Aaper and used as received while dichloromethane were 
distilled in the presence of calcium hydride. Flash column chromatography was 
performed for purification using silica gel (SiO2, particle size 40-63 µm). Stability studies 
were performed in Tris buffer (1 M, pH= 8.02), low glucose Dulbecco’s Modified Eagle’s 
Medium (Sigma, D5523) and fetal bovine serum (Fisher Scientific, SH3007103). 
 CdSe/ZnS core-shell QDs were prepared according to the reported procedure.21 
CdO (0.0514 g, 0.4 mmol), tetradecyl phosphonic acid (TDPA) (0.2232 g, 0.8 mmol) and 
trioctylphosphine oxide (TOPO) (3.7768 g, 9.77 mmol) were loaded into a 50 ml three-
neck flask and heated to 350 ºC under Ar flow. After 3 h the solution becomes optically 
clear and the Se solution (Se (0.042 g, 0.53 mmol) in 2.4 ml trioctyl phosphine (TOP)) 
was swiftly injected into the hot solution. The CdSe QDs were purified and precipitated 
with CHCl3 and MeOH, and finally dissolved in CHCl3. Then, the CdSe core solution is 
mixed with TOPO (4g, 10.3 mmol) and hexadecylamine (HDA) (1.5 g, 6.2 mmol) and 
heated to 150 ºC for 1 h. Diethylzinc (ZnEt2) (1.6 ml, 1.6 mmol) in 2.4 ml TOP and 
hexamethyl-disilathiane (TMS)2S (0.278 ml, 1.3 mmol) in 5.25 ml TOP were used as 
shell solution. After injecting the shell solution the QD mixture was reacted for 1 h at 100 
ºC. The resulting CdSe/ZnS QDs were purified and precipitated with CHCl3 and MeOH, 
and finally stored in toluene. 
 Cationic QDs were prepared through a two-steps ligand exchange reaction. In first 
step TOPO/TOP coated CdSe/ZnS QDs (10 mg, 11.45 pmol) were mixed with HS-C5-
TEG ligands (30 mg) in MeOH. The reaction mixture was stirred at 35 ºC for 24 h under 
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inert atmosphere. In this step, amphiphilic ligands replaced the native hydrophobic 
ligands from the surface of QDs, and the resulting amphiphilic QDs became soluble in 
MeOH. Next step involved the purification of QDs with hexane and addition of dithiol 
cationic ligands (30 mg) to the amphiphilic QDs in MeOH. As a result, dithiol ligands 
slowly substitute monothiol ligands from QDs surface due to its better chelating 
capability compared to monothiol analogues. After 24 h of stirring, methanol was 
evaporated and QDs were dispersed in water. The overall yield of this two-step ligand 
exchange reaction was in 96% (10.98 pmol). Finally the aqueous QDs sample was 
purified by dialysis.  
 The electrospray ionization mass spectrometry (ESI-MS) was acquired at positive 
mode on a Bruker Esquire-LC (Billerica, MA) quadrupole ion trap mass spectrometer, 
equipped with an electrospray ionization source. The electrospray needle voltage was set 
to 3.5 kV, and the capillary temperature was kept as 300 ºC. Usually a voltage of 30 V 
was applied to skimmer 1 and a voltage of 80 - 90 V was applied to the capillary offset. 
Samples (ca. 20 μM) were delivered at 200 μL/h using a syringe pump.  
  The matrix assisted aser desorption/ionization mass spectrometry (MALDI-MS) 
analyses were acquired at positive mode on a Bruker Omniflex time-of-flight mass 
spectrometer (Omniflex), equipped with a 337 nm nitrogen laser, a 1.0 m flight tube, and 
a stainless steel sample target. All mass spectra were acquired in reflectron mode. The 
reflectron voltage was set to 20 kV and the accelerating voltage of 19 kV. On this 
instrument, an average of 50 laser shots was fired to acquire each spectrum, and a laser 
power of 10 % was used, which corresponds to ca. 30 μJ/pulse. A saturated α-CHCA 
stock solution was prepared in 70 % acetonitrile, 30 % H2O, and 0.1 % trifluoroacetic 
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acid, and to this stock solution was added an equal volume of a 2 μM solution of the QD 
1, QD 2 and QD 3 respectively. 1 μL of this mixture was applied to target, and after 
allowing it to dry, the MALDI-MS analysis was performed.  
 TEM samples were prepared by depositing 5 µL of cationic QDs (5 µM) onto a 
300 mesh carbon-coated copper grid. The samples were dried in air at room temperature. 
TEM images were obtained on a JEOL 100CX electron microscope operated at 100 keV 
and analyzed using Image J. 
 DLS experiments and zeta potential measurements were performed using a 
Malvern Zetasizer (Nano series, Malvern Instruments Inc, USA). Samples were sonicated 
and filtered with 0.2 µm syringe filter before measurement.    
 In the cell culture experiments, HeLa cells were cultured at 37 ºC under a 
humidified atmosphere of 5% CO2.The cells were grown in low glucose Dulbecco’s 
Modified Eagle’s Medium (DMEM, 4.0 g/L glucose) containing 10% fetal bovine serum 
and 1% antibiotics (100 U/ml penicillin and 100 μg/ml streptomycin). The cells were 
maintained in the above medium and subcultured once in a four days. 
 In the confocal microscopy experiments, HeLa cells were seeded (10×104 
cells/dish) in a glass-bottom dishes (MatTek Corporation, 14 mm microwell) 24 h prior to 
the experiment. Next day, old media was removed and cells were washed with cold PBS 
and 5 nM QD solution in pre-warmed DMEM media (with 10% serum) was added to the 
cells and incubated for 3 h. Thereafter, cells were washed with PBS three times before 
taking the images. Confocal pictures were obtained on a Zeiss LSM 510 Meta 
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condition. The stirring condition was up to 30 min under Ar flow. Then the reaction 
mixture was allowed to come to r.t. Using TLC to check if the reaction is completed. 
After completion of the reaction, the reaction mixture was dilutes with DCM and wash 
with 5 % HCl (twice), NaHCO3 (twice), and water (once). Compound 2 was obtained by 
using column chromatography with 3:1 = Hexane: EtOAc as eluent in 99 % yield.  
1H NMR (400 MHz, CD3OD): δ 7.46-7.38 (m, 4H, HAr), 7.34-7.18 (m, 11H, HAr), 4.12 (t, 
2H, CH2-CH2-OMs), 2.97 (s, 3H, -O-SO2CH3), 2.15 (t, 2H, -SCH2-), 1.46-1.21 (m, 4H, -
CH2-), 0.93-0.81 (m, 2H, -CH2-). 
Compound 3: NaOH (0.75 g, 11.3 mmol) was dissolved in minimum amount of water. 
Then TEG was added to that aqueous solution under stirring. The solution was heated to 
90 - 100 oC and stirred for 5-10 min. Compound 2 (5 g, 11.3 mmol) was added to the 
solution under stirring.  The reaction mixture was stirred for 24 h at 90 - 100 oC. Then the 
reaction mixture was extracted using 25 % EtOAc in hexane. Compound 3 was obtained 
by using column chromatography with 100 % EtOAc as eluent in 60 % yield.  
1H NMR (400 MHz, CD3OD): δ 7.45-7.38 (m, 4H, HAr), 7.32-7.16 (m, 11H, HAr), 3.75-
3.51 (m, 14H, -CH2-TEG-), 3.37 (t, 2H, -CH2O-), 2.14 (t, 2H, -SCH2-), 1.51-1.26 (m, 6H, 
-CH2-). 
HS-C5-TEG: Compound 3 (1 g, 1.8 mmol) was dissolved in DCM solution, and TFA 
(2.73 ml) and (iPr)3Si-H (0.56 ml) was added into the solution. The reaction mixture was 
stirred for 6 h at r.t. The pure HS-C5-TEG compound was obtained by using column 
chromatography with 1: 1 = EtOAc: Hxane as eluent in 99 % yield. 
1H NMR (400 MHz, CD3OD): 4.49 (t, 2H, O-CH2-CH2-OH ), 3.79 (t, 2H, CH2-CH2-O-
CH2), 3.71-3.55 (m, 14H, -CH2-TEG-), 3.46 (t, 2H, -CH2-CH2O-), 2.52 (t, 2H, -SCH2-), 
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Compound 3: Compound 2 (2 g) was reacted with N(CH3)2-R/EtOH (3 ml) at 35 oC for 2 
days, and used TLC to check if the reaction is completed. Evaporating the solvent and 
wash with hexane to obtain the compound 3 in 99 % yield.  
1H NMR (400 MHz, CD3OD) major peaks assigned: δ 4.21 (t, 2H, COO-CH2-CH2), 3.97 
(brs, 2H, -OCH2-CH2-CH2-N(CH3)3), 3.87 (brm, 2H, COO-CH2-CH2-O), 3.72-3.54 (m, 
12H, -CH2-TEG-), 3.38 (s, 9H, -N(CH3)3), 2.79 (2, 3H, CH3SO3-), 2.34 (t, 2H, CH2-CH2-
COO), 1.75-1.58 (m, 4H), 1.53-1.38 (m, 2H). 
DHLA-TEG-N(CH3)2-Rn: Compound 3 (1 g) was dissolved in 20 ml of EtOH / water 
(1:4) with stirring. NaBH4 (0.15 g) was added and the reaction mixture. The reaction 
mixture was stirred for 1 hr and become colorless. The reaction mixture was diluted with 
water and extracted with CHCl3. The combined organic phase was dried over Na2SO4. 
DHLA-TEG-N(CH3)2-Rn can be obtained after evaporating the solvent in 99 % yield.  
DHLA-TEG-N(CH3)2-R1:1H NMR (400 MHz, CD3OD) major peaks assigned: δ 4.22 (t, 
2H, COO-CH2-CH2), 3.98 (brs, 2H, -OCH2-CH2-CH2-N(CH3)3), 3.94 (brm, 2H, COO-
CH2-CH2-O), 3.71-3.59 (m, 12H, -CH2-TEG-), 3.42 (s, 9H, -N(CH3)3), 2.35 (t, 2H, CH2-
CH2-COO), 1.94-1.86 (m, 2H), 1.8-1.7 (m, 4H), 1.68-1.61 (m, 4H). MS (ESI-MS) calcd 
for C19H40NO5S2+ 426.23, found 426.1 [M]. 
DHLA-TEG-N(CH3)2-R2: 1H NMR (400 MHz, CD3OD) major peaks assigned δ 4.22 (t, 
2H, COO-CH2-CH2), 4.00 (brs, 2H, -OCH2-CH2-CH2-N(CH3)2-), 3.94 (brm, 2H, COO-
CH2-CH2-O), 3.73-3.61 (m, 12H, -CH2-TEG-), 3.26 (s, 6H, -N(CH3)2), 2.35 (t, 2H, CH2-
CH2-COO), 1.94-1.86 (m, 2H)1.78-1.58 (m, 7H), 1.49-1.36 (m, 6H). 
MS (ESI-MS) calcd for C24H48NO5S2+ 494.3, found 494.1 [M]. 
DHLA-TEG-N(CH3)2-R3: 1H NMR (400 MHz, CD3OD) major peaks assigned δ 7.64 
(m, 2H, HAr), 7.47 (m, 4H, HAr), δ 4.94 (s, 1H, -N(CH2)2-CH2-Ar), 4.89 (s, 1H, -
N(CH2)2-CH2-Ar), 4.19 (t, 2H, COO-CH2-CH2), 4.05 (brs, 2H, -OCH2-CH2-CH2-
N(CH3)2-), 3.93 (brs, 1H, COO-CH2-CH2-O), 3.88 (brs, 1H, COO-CH2-CH2-O) 3.74-3.56 
(m, 12H, -CH2-TEG-), 3.3 (d, 6H, -N(CH3)2), 2.8 (s, 3H, CH3-SO3--)2.33 (brs, 2H), 2.02-
1.81 (brs, 7H), 1.71-1.58 (m, 5H), 1.50-1.37 (m, 3H)  
MS (ESI-MS) calculated for C25H44NO5S2+ 502.27, found 500.4 [M-2H]. 
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CHAPTER 3 
THE ROLE OF LIGAND COORDINATION ON THE CYTOTOXICITY OF 
CATIONIC QUANTUM DOTS IN HELA CELLS 
3.1 Introduction 
The cytotoxicity of QDs has become a major obstacle for their safe use in biomedical 
applications,1 including imaging2and delivery.3  QD toxicity strongly depends on QD 
physicochemical parameters including size,4 charge5and stability.6 The role of surface 
chemistry of QDs in determining toxicity is an important consideration since surface 
functionalization is required for biological applications.7 A number of organic ligands, 
e.g. thiolate ligands, have been introduced on the surface of QDs to provide water 
solubility and colloidal stability. 8  Recently, multiple chelating groups have been 
employed to produce stronger affinity to the QD surface and concomitant increase of the 
stability.9 As an example, Mattoussi et al. have demonstrated that multidentate ligands 
provide enhanced stability for CdSe/ZnS QDs under extreme conditions.10 These studies 
focus on the stability of QDs, however, the effect of ligand structure on QD toxicity has 
not been systematically investigated. 
Cationic QDs possess higher cellular permeability than uncharged (neutral) and 
negatively charged QDs, and also provide a complementary surface binding for 
negatively charged biomolecules (e.g., proteins 11  and nucleic acids 12 ) for biological 
applications.13 Cationic QDs, however, face challenges associated with toxicity compared 
to anionic and neutral QDs. 14  To investigate the cytotoxicity of cationic QDs with 
different surface ligand structures we used two types of cationic QDs featuring different 
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very similar but the emission peaks showed modest differences, as is commonly observed 
after surface modification. 19  Moreover, the monothiol-functionalized QDs were less 
fluorescent compared to dithiol-functionalized QDs. This lower quantum yield of 
monothiol-functionalized QDs presumably arises from the higher density of thiolate 
ligands on the QD surface.20 Dynamic light scattering (DLS) data indicated that the 
hydrodynamic size of monothiol-functionalized QDs (16 nm) was slightly larger than 
dithiol-functionalized QDs (ca. 9 nm) while the zeta potentials of these two types of QDs 
were quite similar (ca. +27 mV) (Figure 3.1b).  
The coordination number of the monothiolate and dithiolate ligands can generate 
different ligand coating properties on particle surfaces, particularly the ligand density. 
The ligand amounts on monothiolate QD 1 and dithiolate QD 2 were measured using 
thermal gravimetric analysis (TGA). As shown in Figure 3.2a, the weight loss in QD 1 
was 62% while QD 2 was 43%, providing a calculated ligand amount for QD 1 of 320 
and QD 3 of 220. Green QDs were 2.9 ± 0.5 nm in diameter based on the transmission 
electron microscopy (TEM) image.18 Therefore, the ligand packing densities on QD 1 and 
QD 2 were 12 and 8 nm-2, respectively (Figure 3.1b), indicating monothiolate QD 1 
presented a 1.5-fold increase in charge density compared to dithiolate QD 2. The higher 
packing density observed in QD 1 was presumably contributed from both of the smaller 
footprint of monothiols and stronger hydrophobic interactions between the 11-carbon 
alkyl chains.   
Colloidal stability in physiological media is a significant challenge for biological 
applications of QDs. QD 1 and QD 2 were incubated in low glucose Dulbecco’s Modified 
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generation of cationic dendrimers. Given the ligand exchange is a widely used method for 
nanomaterial functionalization, our study provides a straightforward approach to regulate 
the cytotoxic behaviour of nanomaterials through the design of ligand coordination 
number. 
3.3 Conclusion 
We have investigated the toxicity of cationic QDs, focusing on the influence of surface 
ligand density in HeLa cells. Monothiol-functionalized QDs possess higher cytotoxicity 
compared to dithiol-functionalized QDs due to higher charge density and enhanced 
cellular membrane damage. Taken together, the modulation of the surface ligand density 
and cytotoxicity of nanomaterials by engineering their surface properties will enable the 
application-specific control and expand their biological utility. 
3.4 Experimental section 
All chemicals were purchased from Sigma-Aldrich unless otherwise stated. The organic 
solvents were bought from Fisher and used as received while dichloromethane (DCM) 
was distilled in the presence of calcium hydride. Flash column chromatography was 
performed for purification using silica gel (SiO2, particle size 40-63 µm). Low glucose 
Dulbecco’s Modified Eagle’s Medium (DMEM) (Sigma, D5523) and fetal bovine serum 
(FBS) (Fisher Scientific, SH3007103) were used in cell culture. The reagent necessary 
for the MALDI-MS analysis of the QDs included HPLC grade acetonitrile (Fisher 
Scientific Co LLC, Fair Lawn, NJ), trifluoroacetic acid (Sigma-Aldrich, St. Louis, MO), 
and α-cyano-4-hydroxycinnamic acid (α-CHCA). Milli-Q water from a Millipore 
Simplicity 185 system (Millipore Corp., Billerica, MA) was also used to prepare samples.  
 CdSe/ZnS core-shell QDs were prepared according to the reported procedure.32 
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The preparation of the monothiol-functionalized QDs was through ligand exchange 
process. Monothiolate ligands have placed in MeOH under ligand to QD ratio by weight 
(10: 1), and the solution was stirred at 40 ºC for 4 days. These critical conditions can help 
the monothiol ligands replace most of the hydrophobic TOPO/TOP ligands on the surface 
of QDs and transfer QDs into aqueous solution. The preparation of dithiol-functionalized 
QD was through two steps ligand exchange reaction using the strategy described 
previously.16 In first step, TOPO/TOP coated QDs (10 mg) were mixed with HS-(CH2)5-
TEG-OH ligands (30 mg) in MeOH, and the reaction mixture was stirred at 35 ºC for 24 
h. Next step involved the purification of QDs with hexane and the addition of dithiol 
cationic ligands (30 mg) to the amphiphilic QDs in MeOH. As a result, dithiol ligands 
slowly substitute monothiol ligands from QD surface due to its better chelating capability 
compared to monothiol analogues.33 After 24 h of stirring, MeOH was evaporated and 
QDs were dispersed in water. Both of the aqueous QD sample, including monothiol- and 
dithiol-functionalized QDs, were purified by dialysis. Mass spectra analysis revealed the 
characteristic peaks of the quaternary ammonium derivatives on QD surface, which was 
showed in supporting information. MALDI-MS analyses of QDs were modified based on 
previous method.35 
 DLS experiments and zeta potential measurements were performed using a 
Malvern Zetasizer (Nano series, Malvern Instruments Inc, USA). Samples were sonicated 
and filtered with 0.2 µm syringe filter before measurement.    
 TGA was performed using a TGA 2950 high-resolution thermo-gravimetric 
analyzer (TA Instruments, Inc., New Castle, DE), which was equipped with an open 
platinum pan and an automatically programmed temperature controller. TGA data were 
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obtained as follows: about 2.0 mg of QDs was placed in the TGA pan and heated in a 
nitrogen atmosphere at a rate of 5 °C / min up to 800 °C.  
 A stepwise calculation of the ligand coverage of QDs is based on the following 
equations: 
ligand molar amount= ligand weight/ ligand molar mass…(Eq. 3.1) 
ligand number per QD= ligand molar amount/ QD molar amount…(Eq. 3.2) 
ligand coverage of QD= ligand number per QD/ surface area of QD…(Eq. 3.3) 
(Surface area = 4πr2; r = radius of QD) 
In detail, the concentration of QD 1 solution was first measured using UV-Vis 
spectrometry.34 QD 1 solution (3.71 µM in 500 µl, 1.86 × 10-9 mol) was lyophilized to 
obtain the final weight of 4 × 10-4 g and further used in the TGA experiment. According 
to the TGA data, the weight loss of QD 1 was 62%, indicating the weight of the ligand in 
QD1 solution was 2.48 × 10-4 g. The total ligand molar amount on QD surface can be 
calculated as 5.88 × 10-7 mol based on the molar mass of the ligand (422.69 g/mol) (Eq. 
3.1). Thus, the ligand number per QD can be determined as 316 by dividing molar 
amount of QD by molar amount of ligand (Eq. 3.2). The size of QD 1 was 2.9 ± 0.5 nm in 
diameter based on the TEM image,18 indicating the radius (r) of QD was 1.45 nm. Thus, 
the ligand coverage can be calculated as 12 nm-2 by dividing surface area of QD by the 
ligand number per QD (Eq. 3.3). 
Similar calculation process was used to calculate the ligand coverage of QD 2, 
and it was determined as 8 nm-2. 
 Electrospray ionization mass spectrometry (ESI-MS) was acquired at positive 
mode on a Bruker Esquire-LC (Billerica, MA) quadrupole ion trap mass spectrometer, 
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equipped with an electrospray ionization source. The electrospray needle voltage was set 
to 3.5 kV, and the capillary temperature was kept as 300 oC. Usually a voltage of 30 V 
was applied to skimmer 1 and a voltage of 80 - 90 V was applied to the capillary offset. 
Samples (ca. 20 μM) were delivered at 200 μL/h using a syringe pump. 
  The matrix assisted laser desorption/ionization mass spectrometry (MALDI-MS) 
analyses were modified based on previous method.35 It was acquired at positive mode on 
a Bruker Autoflex III MALDI-TOF mass spectrometer (Bruker Daltonics, Bremen, 
Germany) (Autoflex III). Operating conditions were as follows: ion source 1 = 19.00 kV, 
ion source 2 = 16.60 kV, lens voltage = 8.44 kV, reflector voltage = 20.00 kV, reflector 
voltage 2 = 9.69 kV, pulsed ion extraction time = 10 ns, suppression = 400 Da, and 
positive reflectron mode. Laser strength was optimized to around 50μJ/pulse. A saturated 
α-CHCA stock solution was prepared in 70% acetonitrile, 30% H2O, and 0.1% 
trifluoroacetic acid, and to this stock solution was added an equal volume of a 2 μM 
solution of the QDs. 1 μL of this mixture was applied to target, and after allowing it to 
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Cd standard solutions (20, 10, 5, 2, 1, 0.5, 0.2, and 0 ppb) were measured to build the 
calibration curve before each experiment. Each cell uptake experiment was done in 
triplicate, and each replicate was measured 5 times by ICP-MS. ICP-MS operating 
conditions are as below: rf power 1600 W; plasma Ar Flow rate, 15 ml/min, nebulizer Ar 
flow rate, 0.98 ml/min; dwell time, 45 ms.  
 Cell viability was determined by using alamarBlue® assay according to the 
manufacturer’s protocol (Invitrogen Biosource, USA). In a typical experiment, HeLa 
cells were plated at 15000 cells/well in a 96-well plate 24 h prior to the experiment. On 
the following day, the old media was removed and cells were washed one time with cold 
phosphate-buffered saline (PBS) buffer before putting the different concentrations of QDs 
mixed in the pre-warmed 10% serum containing media. Cells were further incubated for 
24 h (or 3 h) at 37 ºC under a humidified atmosphere of 5% CO2.  Cells were thoroughly 
washed with PBS buffer (three times) and were treated with 220 μL of 10% alamar blue 
in serum containing media. Subsequently, the cells were incubated at 37 ºC under a 
humidified atmosphere of 5% CO2 for 4 h. After 4 h of incubation, 200 μL of solution 
from each wells was transferred in a 96-well black microplate. Red fluorescence, 
resulting from the reduction of Alamar blue solution, was quantified (excitation/emission: 
560 nm/590 nm) on a SpectroMax M5 microplate reader (Molecular Device) to 
determine the cellular viability. Cells without any QDs were considered as 100% viable. 
Each experiment was done in triplicate. 
 The experiment of antioxidant on cell viability was performed as mentioned in 
earlier reports.36 In short, HeLa cells were plated at a density 15000 cells/well in a 96-
well plate on the day prior to the experiment. Next day, the old media was removed and 
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cells were washed one time with PBS. Cells were then treated with N-acetylcysteine 
(NAC) with final concentration of 2 mM for 2 h prior to QD addition (200 nM/well) and 
maintained continuously in the media. After 24 h, the cell viability was measured via 
Alamar blue assay following the above mentioned protocol. 
 The extent of membrane damage by cationic QDs was quantified by G6PD 
release assay kit (Invitrogen, V-23111). HeLa cells were plated (15000 cells/well) one 
day prior to the experiment. On the following day, cells were washed with PBS one time 
and treated with 300 nM of QDs for 3 h. The following steps of the assay were performed 
according to manufacturer’s protocol. The fluorescence reading was measured on a 
SpectroMax M5 microplate reader (Molecular Device) with excitation/emission: 560 nm/ 
590 nm. Percentage of G6PD release was calculated taking fully lysed cells as 100% 
control. 
 For the propidium iodide staining experiment, HeLa cells (50000 cells/ well) were 
plated in a 24-well plate one day prior to the experiment. Next day, cells were washed 
one time with PBS and QD 1 and QD 2 (300 nM in 10% serum containing media) were 
added to the cells. After 3 h of incubation, the cells were washed three times and 
propidium iodide in PBS (final concentration 3 μM) was added to the cells. After 15 
minutes of incubation at 37˚C, the images of the cells were captured using an Olympus 
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CHAPTER 4 
STABILITY OF QUANTUM DOTS IN LIVE CELLS 
4.1 Introduction 
Bright and photostable quantum dots (QDs) with size-tunable fluorescent properties are 
widely employed tools1, 2, 3 for imaging cellular structures4, 5, 6 and events7, 8.The small 
diameters and tailorable surface functionalities of QDs have resulted in their widespread 
use in whole animal9 and cellular imaging1, 2, 3 applications. For these applications, QDs 
are functionalized with hydrophilic monolayers to increase their water solubility10, 11, 12, 
and with functional groups for targeting and biomolecular recognition. 11, 12 QDs with 
heterobifunctional thiol monolayers11, 12 provide much smaller hydrodynamic diameters 
(ca. 4-10 nm) than other surface modification methods such as amphiphilic polymer 
encapsulation,1 an important issue for both cellular12 and in vivo applications9 where 
larger particle size generates issues in terms of uptake and excretion. These 
functionalized thiol-based monolayers minimize non-specific binding and improve 
colloidal stability.11, 12 For example, monolayers with dihydrolipoic acid anchor groups, 
poly(ethylene glycol) (PEG) spacers, and streptavidin or fluorescent dye end groups have 
been used for single molecule tracking and sensing inside cells.12 Improvements to the 
colloidal and pH stability of these functionalized QDs have been made by tuning the 
monolayer structure. For example, Mattoussi et al. showed that monolayers with 
multidentate thiolate anchor groups are more stable under a variety of environmental 
conditions than monolayers with monothiolate anchor groups.13 
Effective use of functionalized QDs for imaging and sensing in living cells and 
animals, however, requires an accurate assessment of monolayer stability. Monolayer 
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degradation will compromise the QD utility; biogenic thiols such as cysteine and 
glutathione (GSH) with intracellular concentrations as high as 10 mM can displace 
thiolate-bound ligands from nanoparticle surfaces.14, 15 , 16 , 17 The resultant loss of the 
protective monolayer coating results in QD aggregation in cells resulting in toxicity.18 
Moreover, if the QD monolayer contains a targeting antibody or ligand for the purpose of 
tracking a given protein/receptor,7, 8 monolayer loss will diminish or eliminate targeting, 
providing misleading or irreproducible results. Finally, monolayer displacement modifies 
QD optical properties; QDs coated with GSH or cysteine have shown reduced blinking19 
and enhanced emission intensity,19, 20, 21 making monolayer stability an important issue 
for quantitative applications. 
 Clearly monolayer stability is required for effective applications of QDs in 
biology. To date, however, the intracellular stability of QD monolayers has not been 
quantified due to inadequate measurement tools. Here, we describe a new method based 
on the combination of laser desorption/ionization mass spectrometry (LDI-MS) and 
inductively coupled plasma mass spectrometry (ICP-MS) that enables QD monolayer 
stability to be quantitatively assessed inside cells (Figure 4.1c). We demonstrate the 
utility of this new approach by comparing the stability of four cationic CdSe/ZnS QDs 
(Figure 4.1a) with the same dithiolate monolayer but different particle sizes/colors, with 
core diameters ranging from 2.9 nm to 5.9 nm and hydrodynamic diameters of 8 nm to 18 
nm (Figure 4.1b). We also compare the stability of QDs functionalized with dithiolate and 
monothiolate groups. In this method, the total amount of the QDs taken up by the cells is 
first quantified using ICP-MS. In a parallel measurement, monolayer amount on QD 
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prior to analysis. (d) Calibration curve: Ion abundance ratios from QD535 (m/z 392) and 
QD-IS (m/z 464) for QD535 (400-9600 fmol) and QD-IS(800 fmol). (e) Remaining 
monolayer of QD535 without (blue) and with (red) the addition of GSH to the cell lysate, 
showing substantial monolayer degradation with the presence of GSH in lysate. 
The ability of the LDI-MS to measure the amounts of QD monolayers was first 
validated using cell lysate with known amounts of QDs spiked. As an example, 4000 
fmol of QD535 was spiked into HeLa cell lysate with and without GSH added (Figure 
4.2b and 4.2c).  After incubating the QDs in cell lysate for 3 h, the solutions were mixed 
with internal standard QD-IS (800 fmol) and analyzed by LDI-MS (Figure 4.2b). The 
“mass barcode” abundance ratio of QD535 (m/z 392) relative to QD-IS (m/z 464) is 1.34 
 0.07. Applying the calibration curve (Figure 4.2d), in which the “mass barcode” ratios 
were correlated with monolayer concentration ratios, QD535 monolayer amount is 
determined as 4100  200 fmol (blue column in Figure 4.2e). Note that we defined that 
one QD particle has one intact surface monolayer. Consequently, on the calibration curve 
the QD concentration and the monolayer concentration were the same. Considering that 
4000 fmol of QD535 was initially spiked into lysate, this result indicates that no 
monolayer release was observed, and the recovery rate was 103  5%. For comparison, 
the ion abundance ratio of QD535 in cell lysate to which 10 mM GSH was added is 0.69 
 0.05 (Figure 4.2c), which corresponds to 2100  200 fmol of monolayer (red column in 
Figure 4.2e). Therefore, this result indicates that only 53  5% of the original monolayer 
of QD535 remains after exposure to 10 mM GSH. The same experiments were also done 
for the other five QDs, and in each case GSH causes monolayer release. 
Determination of the monolayer stability of QD in living cells was obtained using 
QDs with positively-charged monolayers designed to facilitate uptake.22 Confocal 
microscopy was used to visualize the cellular uptake of QDs. Our previous work22 and 
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others25 have shown that the cellular uptake of cationic nanoparticles can occur through 
endocytosis, consistent with our observations. Confocal microscopy images of the QDs 
used in this study demonstrate that different sized QDs with the same surface 
functionality have the same intracellular distribution and are mostly found in lysosomes 
after incubation for 24 h (Figure 4.5). Previous studies have shown that biogenic thiols 
such as cysteine and cysteamine are actively accumulated in lysosomes to concentrations 
as high as tens of mM,26, 27, 28 indicating a possible mechanism for QD monolayer release. 
Compared with the lysate studies, measuring intracellular particle stability introduces an 
additional complication in assessing monolayer stability, as cellular uptake of QDs will 
vary as a function of particle size29 and monolayer structure22. To address this issue, the 
total amount of the QDs taken up by the cells was first quantified using ICP-MS. Total 
Cd concentrations were measured and then converted to particle amounts. In parallel, a 
fraction of the same sample was analyzed by LDI-MS to determine the monolayer 
amounts remaining on the QD surface. The difference between the QD particle amount in 
cells as determined by ICP-MS and monolayer amount left on QD surface as determined 
by LDI-MS provides the amount of monolayer released from the QD (Figure 4.1c). 
For our studies, each of the five QDs (QD535, QD565, QD595, QD630, and 
QD535(m))  was incubated with HeLa cells for 3 h, 6 h, 9 h, and 24 h. No cell 
morphology changes were observed after incubation. At each time point, the cells were 
lysed, and then analyzed for Cd (ICP-MS) and monolayers (LDI-MS). For each QD, 
uptake of QD particles as determined by ICP-MS increased with time (Figure 4.3a-e 
[black curves]). The monolayer amount as determined by LDI-MS (Figure 4.3a-e [red 
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dependent monolayer stability is most likely related to nanoparticle curvature and surface 
coverage, as experimental and theoretical studies have shown that larger nanoparticles 
with flatter surfaces lead to less surface coverage than smaller more strongly curved 
nanoparticles.30, 31, 32 Consequently, there are more free surface atoms (e.g., Zn for the 
QDs in this study) on larger particles, enabling greater accessibility for biogenic GSH 
and/or other thiols. Similar phenomena were reported by Mattoussi and co-workers for 
AuNPs, observing that 5 nm AuNPs are more resistant to decomposition by sodium 
cyanide than 10 or 15 nm AuNPs with the same dithiolate monolayer.33 
Our results indicate that the monolayer anchor groups (monothiol vs. dithiol) also 
affect QD monolayer stability. Previous work has shown that dithiolate ligands enhance 
the colloidal and pH stability of gold NPs and QDs relative to monothiolate groups.11, 33 
Our experiments provide a quantitative measure of this increased stability in live cells by 
comparing mono- and dithiol QDs (QD535 and QD535(m)) with the same core diameter 
(Figure 4.3a and 4.3e). These studies confirmed that the dithiolate anchor group provided 
significantly greater intracellular monolayer stability than the monothiolate group: after 
24 h, 40% of the monothiolate-bound monolayer was lost while complete monolayer 
retention was observed with the dithiolate monolayer (Figure 4.4f). Note that QD535 and 
QD535(m) have 5 and 11 carbons in the hydrophobic alkane chain, respectively. For a 
better comparison, another QD535(m) with 5 carbons in the hydrophobic part was also 
synthesized, however, the shorter alkane chain together with monothiol anchor group 
produced unstable QDs. These results further highlight the importance of the anchor 
groups and ligand hydrophobicity on QD stability. 
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diameter), shows excellent stability in cells for up to 24 h. In contrast, the largest QD (5.9 
nm core diameter) loses ca. 70% of its monolayer over the same 24 h. Similar differences 
in stability were observed when a dithiolate monolayer is replaced by a monothiolate 
monolayer, with monolayer stability decreasing by 40%. Taken together, these studies 
show that proper choice of both particle size and monolayer structure is critical for live-
cell imaging applications. Our study indicates several strategies to create QDs with 
superior monolayer stability by choosing relatively smaller QDs and using bidentate 
ligands, e.g., dithiolate. Given the importance of QDs for live cell imaging, our studies 
likewise demonstrate the continuing need for more stable QD functionalization strategies. 
4.4 Experimental section 
The TOPO capped CdSe/ZnS core-shell QDs were prepared according to reported 
procedures.35 The monolayer molecules in Figure 4.1a were synthesized according to our 
previous work4.The preparation of monothiol functionalized QDs were through ligand 
exchange process. Monothiol ligands were placed in methanol under ligand to QD ratio 
by weight (10:1), and the solution was stirred at 40 ºC for 4 days. These critical 
conditions can help the monothiol ligands replace most of the hydrophobic TOPO/TOP 
ligands on the surface of QDs and transfer QDs into aqueous solution. The preparation of 
dithiol functionalized QD was through two steps ligand exchange reaction using the 
strategy described previously.35 Both of the aqueous QDs sample, including monothiol 
and dithiol functionalized QDs, were purified by dialysis. 
 HeLa cells (60,000 cells/well) were grown on a 24-well plate in low-glucose 
Dulbecco’s modified Eagle’s medium (DMEM; glucose (1.0 g L-1)) supplemented with 
10% fetal bovine serum (FBS) and 1% antibiotics (100 I.U./ml penicillin and 100 mg/ml 
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streptomycin). Cultures were maintained at 37 ºC under constant saturated humidity with 
5% CO2. After 24 h of plating, the cells were washed five times with cold phosphate 
buffer saline (PBS). Then, 500 µL of media containing QD (120 nM for QD535, QD565, 
QD595, and QD630; 240 nM for QD535(m)) was added. Following a certain culture time 
(3 h, 6 h, 9 h, or 24 h), the cells were washed five times with cold PBS to remove extra 
QDs and lysed for 10-30 min with a lysis buffer (200 µL; Genlantis, USA). Each sample 
was prepared in six replicates, which were split with half being separately analyzed by 
ICP-MS and LDI-MS. To prepare cell lysates, HeLa cells (60,000 cells/well) were grown 
on a 24-well plate for 24 h, and lysed with 200 µL of lysis buffer. To increase the 
intracellular concentration of GSH, 200 µL of media containing 10 mM glutathione ethyl 
ester (Sigma, USA) was incubated with HeLa cells for 1 h, and then replaced by media 
containing QD for a further 6 h incubation. The intracellular concentration of total GSH 
was measured using the glutathione detection kit (BioVision, USA).  
 After cellular uptake, the lysed cells were digested with 0.5 mL of fresh aqua 
regia (highly corrosive and must be use with extreme caution!) for 10 minutes. The 
digested samples were diluted into 10 mL with de-ionized water. A series of cadmium 
standard solutions (10, 5, 2, 1, 0.5, 0.2, 0 ppb) were prepared before each experiment. 
Each cadmium standard solution also contained 5% aqua regia. The cadmium standard 
solutions and QD sample solutions were measured on an Elan 6100 ICP mass 
spectrometer (PerkinElmer SCIEX, USA). The instrument was operated with 1100 W RF 
power, and the nebulizer Ar flow rate was optimized around 0.9 - 1.1 L/min. 
 After cellular uptake, the lysed cells were mixed for 15 min with QD-IS (typically 
400 or 800 fmol) as the internal standard. Following ultracentrifugation at 60,000 rpm 
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(ca. 139,000 g) for 20 min, the QDs taken up by cells and the internal standard were 
collected as part of precipitate and washed with 60% acetonitrile/40% water. Later, the 
samples were transferred onto a MALDI target for LDI-MS analysis without adding any 
organic matrix. External calibration curves were generated before sample analyses. Each 
QD with the QD-IS at different ratios were spiked into cell lysate and vortexed for 15 
min. The QD mixtures were collected by the centrifugation, washed, and analyzed by 
LDI-MS. The intensity ratios of the “mass barcode” ions for QDs and QD-IS were 
determined and plotted against the QD concentration ratios to generate a calibration 
curve. The QD monolayer amounts were then determined by using the internal standard 
and comparing to the calibration curve. To measure monolayer stability in cell lysate 
(Figure 4.2), 4000 fmol of QD535 was spiked into HeLa cell lysate (200 µL) with and 
without added 10 mM GSH. After incubating this QD in cell lysate at 37 ºC for 3 h, 800 
fmol of QD-IS was added. Then, the mixture was immediately centrifuged, and the 
resulting precipitate was subjected to LDI-MS analysis. All of the LDI-MS measurements 
were carried on a Bruker Autoflex III MALDI-TOF mass spectrometer (Billerica, MA, 
USA). All mass spectra were acquired in the reflectron mode and represent an average of 
500 laser shots at a repetition frequency at 100 Hz. The accelerating voltage was set to 19 
kV. The laser power was optimized in the range of 50-90 % for each sample. The Bruker 
software (FlexAnalysis Version 3.3) was used for data analysis. Each sample was 
measured 10 times. 
 Measurement of QD particle concentrations by ICP-MS. In the Step 1, the 
absorbance wavelength of each TOPO-QD in toluene was measured. The absorbance 
wavelengths (λ) were used to calculate CdSe core sizes (a) according to equation 1 
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adapted from Peng and coworkers.36 The CdSe core size should not change after the 
ligand-exchange reaction. The number of Cd atoms in each QD particle (NCd/QD) were 
calculated according to equation 2 adapted from Bawendi and coworkers.37  
D = (1.6122×10-9)λ4 – (2.6575×10-6)λ3 + (1.6242×10-3)λ2 – 0.4277 λ + 41.57                (1) 
In equation 1, D (nm) is the core size of CdSe, and λ (nm) is the wavelength of the first 








/                    (2) 
 
In equation 2, NCd/QD is the number of Cd atoms in each QD particle, and Vunit is the 
volume of the unit cell for CdSe wurtzite crystal which contains two Cd atom in one unit 
cell. The bulk CdSe wurtzite unit cell volume is 112 Å3. 
Table 4.1. Calculations of Cd atoms in a single QD particle. 
QDs λabs (nm) CdSe size (Å) NCd/QD 
QD535/QD535(m) 518 25.37 152.12 
QD565 538 28.21 209.14 
QD595/QD-IS 582 38.86 546.68 
QD630 600 45.83 896.76 
 
In the Step 2, take 10 µL of each QD in Fig. 1a, and dilute into 100 µL with water 
(dilution factor is 10). Take 10 µL of diluted QD solution and digest with 0.5 mL of aqua 
regia for 10 minutes, and dilute into 10 mL. The final solution containing 5% aqua regia 
was subjected to ICP-MS analysis. All samples were analyzed in triplicate. The Cd 
amounts in the ICP-MS samples are denoted as X ng. Therefore, the QD particle 










QD           (3) 
In equation 3, X (ng) is the Cd amount in 10 µL of diluted QD solution measured by ICP-
MS. CdMw is the atomic weight of Cd (112.411 g/mol). The number 10 is the dilution 
factor. 
 The Cd amounts in each cell sample was measured by ICP-MS, and denoted as Y 






QD           (4) 
 HeLa cells were seeded (12×104 cells/dish) in glass-bottom dishes (MatTek 
Corporation, 14 mm microwell) 24 h prior to the experiment. On the next day, old media 
was removed, and cells were washed with cold PBS. Then, 1.5 mL of QD solution (120 
nM for each QD) in pre-warmed DMEM media (with 10% serum) was added to the cells 
and incubated for another 24 h. Thereafter, cells were washed with PBS three times 
before taking the images. Confocal microscopy images were obtained on a Zeiss LSM 
510 Meta microscope using a 63 × objective. LysoTracker® Red DND-99 and 
LysoTracker® Green DND-26 were obtained from Invitrogen. 100 nM of LysoTracker® 
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CHAPTER 5 
DIFFERENTIATION OF CANCER CELL TYPE AND PHENOTYPE USING 
QUANTUM DOT-GOLD NANOPARTICLE SENSOR ARRAYS 
5.1 Introduction 
Early detection and screening of cancerous cell states is a crucial determinant for 
successful treatment and patient survival. Current methodologies for cancer diagnosis are 
based on the detection of biomarkers, such as genes, proteins, or other specific 
molecules.1 , 2  For example, prostate specific antigen (PSA) is a widely used clinical 
biomarker for prostate cancer in the early detection,3, 4 and receptor tyrosine kinases 
(RTKs) are surface biomarkers used for cancer cell monitoring.5, 6 Antibody arrays,7 DNA 
microarrays,8 mass spectrometry,9 and electrophoresis,10 have been employed as useful 
tools for cancer diagnosis based on the understanding of the cancer biomarkers. However, 
single “lock-key” recognition of specific biomarker is limited by the requirement of pre-
knowledge about the disease biomarkers. Lack of a unique marker or combination of 
biomarkers for cell types often poses a major challenge in the early detection of cancer.11 
Therefore, alternate methodologies with greater selectivity, higher sensitivity, rapid 
detection ability, and exploiting the overall cellular signatures would enhance our ability 
to detect and identify cancer.    
 Selective array-based sensing methodologies provide potential alternatives to 
specific recognition approaches, relying on the differential affinities for analyte 
identification.12 Sensors have been developed utilizing this approach for identification of 
cancer cells, using fluorescent polymers,13, 14 magnetic glyco-nanoparticles,15 and non-
covalent conjugates of gold nanoparticles and fluorophores.16, 17  
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We introduce here a new nanoparticle-based sensor for discriminating between 
cell types and states by their surface properties. This sensor strategy uses quantum dots 
(QDs) and gold nanoparticles (AuNPs) as recognition elements. QDs serve as 
transducers,18 relying on their unique optical properties, such as high quantum yield, 
excellent photostability and spatially resolvable multiple emission signals.19, 20 AuNPs 
serve to modulate the fluorescence response of the sensor, employing distance-dependent 
quenching of QD emission.21 With these unique physicochemical properties of QDs and 
AuNPs, we fabricated a sensing system using two QDs (green: GQD and red: RQD) and 
one AuNP for cell state discrimination (Figure 5.1). Variation in fluorescence provides 
distinct patterns to discern between different cell types/states. Moreover, this QD-AuNP-
based sensor achieves dual-channel fluorescence output from each particle mixture, 
providing four fluorescence signals with single excitation that enables rapid, effective, 
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phospholipids, carbohydrates and membrane proteins,29 our sensor would be expected to 
achieve nanoparticle-cell surface recognition by differential competitive and selective 
non-covalent interactions. 
 Confocal microscopy was employed to visualize the interactions between 
nanoparticles and cell surfaces. A fluorescent ring was clearly observed around the HeLa 
cell surfaces after incubation with the |QD|M for 15 min, indicating efficient and rapid 
attachment of the cationic QDs on the negatively charged cell surfaces (Figure 5.3a-d). 
Furthermore, the merged image of red and green channels indicated the co-assembly of 
the two QDs in |QD|M on the cell surfaces. Upon incubation with |QD/AuNP|M, 
fluorescence intensities of the QDs on the cell surfaces became weaker (Figure 5.3f-h), 
suggesting co-localization of the QDs and AuNPs on the cell surfaces leading to 
fluorescence quenching by the AuNPs. To investigate the potential cellular uptake during 
the incubation of nanoparticles with cell suspensions, the z-stack confocal images and 3D 
projections were applied to investigate QD distribution (Figure 5.8). GQDs were 
incubated with cell suspensions for 15 min before recording the z-stack images that were 
used to generate 3D projections of the GQD distribution. Clearly, the 3D projections 
showed the green fluorescence of QDs on the cell surface, and no obvious fluorescence 
was observed inside the cell. This result indicated that there was absence of cellular 
uptake of QDs during the 15 min incubation with cell suspensions. Taken together, the 
confocal fluorescence images indicated a recognition-mediated assembly behavior of the 
sensor elements on the cell surfaces. The assembly behavior of the QDs demonstrated the 
potential of the system for both selectivity-based sensing and imaging applications.  
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We have successfully demonstrated the ability of a nanoparticle-based sensing system to 
discriminate four types of cancer cells as well as isogenic normal, cancerous, and 
metastatic cells. Notably, the sensing approach relies on the phenotypic differences in the 
physicochemical properties of cell surfaces. In the sensor, the use of QDs as both the 
recognition elements and transducers not only presented a stable signal transduction and 
the simultaneous signal acquisition from a single well of the microplate, but also 
provided a ‘toolkit’ for direct visualization of selectivity-based cell surface interactions. 
Taken together, this unbiased sensor provides a simple but effective method to profile 
different cell types and states, with the potential of cell surface sensing and imaging for 
point-of-care diagnosis. 
5.4 Experimental section   
All chemicals were purchased from Sigma-Aldrich unless otherwise stated. The organic 
solvents were bought from Pharmco-Aaper or Fisher Scientific and used as received 
except for dichloromethane that was distilled in the presence of calcium hydride. 
Dulbecco’s Modified Eagle’s Medium (DMEM) (Sigma, D5523) and fetal bovine serum 
(Fisher Scientific, SH3007103) were used in cell culture.  
 Trioctylphosphine oxide/ trioctylphosphine/ hexadecylamine (TOPO/TOP/HDA)-
capped CdSe/ZnS core-shell quantum dots were prepared according to reported 
procedures. 35  6 nm dodecanethiol-protected gold nanoparticles (AuNPs-DT) were 
prepared according to Miyake’s heat-induced size evolution of gold nanoparticles with a 
slight modification. 2 nm AuNPs-DT were heated to 165 ºC at the heating rate of 2 ºC 
/min and held for 30 min at 165 ºC.36 Ligand exchange reactions were used to obtain the 
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CH2-CH2-O), 3.75-3.57 (m, 12H, -CH2-TEG-), 3.34 (s, 6H, -N(CH3)2-CH3), 2.34 (t, 2H, 
CH2-CH2-COO), 1.8-1.69 (m, 3H), 1.68-1.57 (m, 4H), 1.4-1.27 (m, 9H), 0.89 (s, 3H, -
N(CH3)2-CH3). MS (ESI-MS) calculated for C24H50NO5S2+ 496.3, found 496.2 [M+].  
In the confocal microscopy experiments, HeLa cell (human cervical cancer cell) 
suspension (10 µL, 10000 cells) was added to |QD|M or |QD/AuNP|M solution (200 µL) 
for 15 min incubation. The mixture solution was transferred into a glass-bottom dish 
(MatTek Corporation, 14 mm microwell). Confocal microscopy images were obtained on 
a Zeiss LSM 510 Meta microscope using a 63× objective. Differential interference 
contrast images (DIC) were collected using a bright light source. Different excitation 
lines and emission spectra windows were used for different colors of quantum dot: GQD 
was excited with a 488 nm Argon laser and the emission window was 505-530 nm; RQD 
was excited with a 543 nm He-Ne laser and the emission window was beyond 650 nm. 
The z-stack confocal images were obtained from a series of images (time, z, x-y), and the 
3D projections were generated from z-stack images with 11 z-slices and z-slice thickness 
of 2 µm. Z-stack confocal images and 3D projections showed the GQD distribution after 
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sensing array |QD|M was prepared by mixing GQD (50 nM) and RQD (50 nM) in 1 mM 
sodium phosphate buffer (pH 7.4). |QD/AuNP|M was prepared by mixing GQD (50 nM), 
RQD (50 nM), and AuNP (10 nM) in 1 mM sodium phosphate buffer (pH 7.4) for 15 
min. 200 µL of each solution (|QD|M or |QD/AuNP|M) was loaded into a 96-well plate and 
fluorescence intensities of complexes were recorded at 550 nm and 590 nm on a 
Molecular Devices SpectraMax M5 microplate reader with excitation at 420 nm. After 
measuring the initial fluorescence intensities (I0), these arrays were incubated with cell 
suspension (10 µL, 10000 cells/well) to determine the final fluorescence intensities (I). 
The fluorescence response patterns were plotted as the ratios of final to initial QD 
fluorescence intensities (I/I0) from |QD|M and |QD/AuNP|M. 
The fluorescence change (I/I0) patterns were subjected to linear discriminant 
analysis (LDA) using SYSTAT (version 11.0) to classify and identify different cells. LDA 
is a supervised multivariate method that is used to separate classes of objects or assign 
new objects to appropriate classes. The analysis generates a new space given by the 
canonical discriminant factors (LD vectors), which describes best similarities and 
differences between groups under consideration. The raw fluorescence response patterns 
were transformed to canonical patterns where the ratio of between-class variance to the 
within-class variance was maximized according to the pre-assigned grouping. We 
followed the “leave-one-out” method to identify the unknown cell test by checking the 
Mahalanobis distance in LDA. The Mahalanobis distance is the distance of a case to the 
centroid of a group in a multidimensional space and is calculated for the new case to the 
centroid of respective training samples. The new case is assigned to the group with the 
shortest Mahalanobis distance.  
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CHAPTER 6 
FABRICATION OF MULTIRESPONSIVE BIOACTIVE NANOCAPSULES 
THROUGH ORTHOGONAL SELF-ASSEMBLY 
6.1 Introduction 
Multifunctional nanomaterials are important platforms for "smart" applications, 
combining the properties of their components1 to provide synergistic systems2 capable of 
achieving multiple objectives. Through the appropriate choice of attributes, 
multifunctional materials can overcome challenges that cannot be solved by their 
individual components,3 including the ability to dynamically adjust their properties and 
functions in response to both endogenous4 and external5 environmental stimuli. Several 
construction challenges, however, must be addressed for these systems to be useful, such 
as control over the size, stability and dynamic properties.6 
Many systems used for bionanotechnology employ covalent conjugation 
approaches to generate stable nanostructures. 7  However, these building elements are 
fixed, making it difficult to further modulate the structure and provide stimuli 
responsiveness. Supramolecular chemistry provides an alternative fabrication strategy 
that addresses the construction challenges of multifunctional materials through multiple 
noncovalent interactions to generate controllable and stimuli-responsive structures. 8 
These supramolecular structures are generated through programmed self-assembly of 
building blocks (e.g., synthetic materials and biomolecules) by using a broad palette of 
available noncovalent interactions, including hydrogen bonding, hydrophobic interactions 
and electrostatic affinities to induce biomimetic assembly. 9  Recent examples of this 
bioinspired assembly strategy include hybrid assemblies,10 peptide amphiphile vesicles11 
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and protocell models.12 
Integration of nanoparticles (NPs) into supramolecular structures provides access 
to the physical13 and structural14 properties of the particles. In particular, self-assembly of 
NPs at the liquid-liquid interface is a straightforward pathway to generate core-shell 
nanoparticle-stabilized capsules (NPSCs). 15  Seen from a biomedical perspective, the 
NPSC platform incorporates the unique physicochemical properties of the NPs into the 
shell while providing an interior hydrophobic space suitable for the transport of drugs and 
other functional agents.16 
Here we present the integration of multiple functional building blocks into a 
NPSC-based platform by means of diverse supramolecular interactions (Figure 6.1). In 
these constructs, CdSe/ZnS core-shell quantum dots (QDs) are conjugated with 
polyhistidine-tagged proteins by exploiting the metal affinity of the histidine residues on 
the QD surface. These anionic QD-protein complexes further interact electrostatically 
with cationic gold nanoparticles (AuNPs) that themselves are pinned to the capsule 
surface through a combination of hydrogen bonding and electrostatic interactions with 
the oil core. The resultant supramolecular nanocapsules demonstrate multifunctional 
properties in cellular studies, such as fluorescent tracking of intracellular bioconjugates, 
stimuli-responsive protein release and co-delivery of proteins and hydrophobic 
endosome-disrupting agents to provide cytosolic protein delivery. 
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mCherry (Figure 6.2a), enabling the use of fluorescence resonance energy transfer 
(FRET) to track the association process. The FRET studies of QD-mCherry conjugates 
were performed in phosphate-buffered saline (PBS, pH 7.4). The loss of the QD emission 
was accompanied by an increase in the mCherry emission as the number of mCherry 
molecules per QD (N) increased (Figure 6.2b). The FRET phenomena of the QD-
mCherry conjugates were maintained in PBS that contained 10% serum (Figure 6.2c), 
demonstrating the stability of QD-mCherry conjugates in the presence of serum proteins. 
An important aspect of metal-coordination conjugation is that the complexes can 
be disrupted by competing molecules. The release of polyhistidine-tagged protein from 
the particle surface can be achieved by the treatment of the conjugates with histidine or 
its analogues (e.g., imidazole).18  Here we used histidine as a biocompatible external 
stimulus to investigate the binding events in the QD-mCherry conjugates. After addition 
of histidine to the solution of QD-mCherry conjugates (N= 6, where the fluorescence of 
QD was quenched by mCherry), the fluorescence recovery of QDs was accompanied by 
the decreasing fluorescence of mCherry (Figure 6.2d). The results indicated that histidine 
can disrupt the FRET process in the QD-mCherry conjugates and release mCherry from 
the QD surface in a concentration-dependent manner. 
We hypothesized that negatively charged QD-mCherry conjugates (zeta potential 
of the conjugates was ca. -30 mV) could be used as noncovalent crosslinkers to provide 
lateral stability to the NPSC structure. Anionic QD-mCherry conjugates and cationic 
AuNPs were self-assembled at the water-oil interface by means of electrostatic 
interactions to form NPSC_QD-mCherry (Figure 6.1b). NPSC_QD-mCherry was 
characterized by using transmission electron microscopy (TEM; Figure 6.2e) and 
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capsule potentially useful in biological applications. The utility of NPSC_QD-mCherry 
was tested through uptake studies in HeLa cells with cellular uptake and distribution 
analyzed using confocal laser scanning microscopy (CLSM) and flow cytometry. 
NPSC_QD-mCherry presented a dominant red fluorescence (Figure 6.3a) inside the cells. 
No green fluorescence was observed in the confocal images, indicating the FRET 
efficiency and hence stability of the QD-mCherry complexes.  
The intracellular distribution of NPSC_QD-mCherry was further investigated 
using green-emitting lysotracker due to the negligible fluorescence of QDs in the green 
channel (Figure 6.3a2). A significant co-localization of red fluorescent NPSC_QD-
mCherry and green fluorescent lysotracker was observed after the incubation with HeLa 
cells for 1 h (Figure 6.3b), which indicated that NPSC_QD-mCherry was taken up as 
expected via endocytosis19 and subsequently trapped in endosomes/lysosomes. 
Endosomal/lysosomal entrapment limits the utility of delivered 
biomacromolecules.20 We investigated the abilities of two orthogonal chemical reagents, 
histidine and chloroquine (CQ), to serve as stimuli to regulate the intracellular 
distribution and binding phenomena of QD-mCherry conjugates. Histidine can be used to 
disassemble the QD-mCherry conjugates due to the competitive binding toward the 
hexahistidine-tags on mCherry; CQ is a weak base that can destabilize 
endosomal/lysosomal membranes.21 NPSC_QD-mCherry was incubated with HeLa cells 
for 1 h before treatment with each reagent. Punctate fluorescence was observed for 
mCherry in the cells that had internalized NPSC_QD-mCherry after treatment with 
histidine or CQ alone (Figure 6.3c and 6.3d). In contrast, mCherry was distributed 
throughout the cytosol after the co-treatment with histidine and CQ (Figure 6.3e). 
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After the internalization of NPSC-CQ_QD-mCherry into the cells, punctate fluorescence 
of mCherry was observed (Figure 6.5a), indicating that as above that dual triggering was 
required. As expected, disperse fluorescence of mCherry was observed in the cytosol 
after delivery of NPSC-CQ_QD-mCherry followed by treatment with histidine (Figure 
6.5b). Significantly, these studies demonstrated the dual-delivery capability of NPSC-
CQ_QD-mCherry; it can deliver both the hydrophilic proteins and hydrophobic 
endosome-disrupting agents by making use of both its exterior and interior 
simultaneously. 
The results showed qualitatively that the proteins can be released into the cytosol 
using appropriate triggers. Fluorescence intensity analysis was used to quantify the 
cytosolic and vesicular distribution of the intracellular fluorescent proteins. 23  The 
cytosolic and endosomal/lysosomal fluorescence intensity can be determined by 
analyzing the fluorescence intensity profiles along with the line in Figure 6.5a and 6.5b. 
Pixels with high fluorescence intensities (200-255) in the punctate fluorescent spots were 
considered to originate from endosomal/lysosomal fluorescence, while pixels with low 
fluorescence intensities (30-85) observed in the disperse fluorescent area were considered 
to be due to cytosolic fluorescence (Figure 6.5c). 
The fluorescence intensity profile of a single cell was measured to allow the 
analysis of the frequency distribution of pixels with high/low fluorescence intensities. As 
shown in Figure 6.4d, cells that had internalized NPSC-CQ_QD-mCherry showed a 
majority of pixels with very low fluorescence intensities. After treatment with histidine, 
however, a broad distribution of pixel intensities was observed, in agreement with the 
reported fluorescence signal distributions of proteins that escape from endocytic vesicles 
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to the cytosol.23 
The frequency distribution of fluorescence intensities can be used to 
quantitatively compare the degree of fluorescence distribution in the endosome/lysosome 
and cytosol.23a, 24  Cytosolic fluorescent pixels (fluorescence intensities 30-85) in the 
whole cell were counted to determine the percentage of cytosolic mCherry when 
NPSC_QD-mCherry and NPSC-CQ_QD-mCherry were internalized into cells. Cytosolic 
fluorescence of mCherry was noticeable in NPSC_QD-mCherry upon co-treatment with 
histidine and CQ as well as NPSC-CQ_QD-mCherry with treatment by histidine alone 
(Figure 6.5e). The ratio of cytosolic pixel counts (fluorescence intensities 30-85) to 
endosomal/lysosomal pixel counts (fluorescence intensities 200-255) under different 
experimental conditions was shown in Figure 6.5f. The results indicated that the NPSC-
CQ_QD-mCherry internalized into cells treated with histidine presented a significantly 
higher level of cytosolic fluorescence of mCherry compared to cells that had internalized 
NPSC_QD-mCherry without any treatment (ca. 10-fold). Moreover, a substantially 
higher degree of endosomal/lysosomal release was observed with the encapsulated CQ 
relative to the externally added CQ, presumably due to higher local concentration of CQ 
in the endosome/lysosome. 
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required for release of the cargo protein to the cytosol. These studies demonstrate that 
utilization of multiple supramolecular interactions in nanocapsules provides a potent 
strategy for the creation of responsive systems that serve as potential platforms for next-
generation smart materials for biological and functional materials applications.  
6.4 Experimental section 
All the chemicals were purchased from Sigma-Aldrich or Fisher Scientific, unless 
otherwise specified. LysoTracker® Green DND-26 was obtained from Invitrogen. The 
chemicals were used as received. The TEM sample of NPSC_QD-mCherry was prepared 
by drop-casting onto a 300-mesh nickel grid coated with formvar film. The TEM images 
of samples were measured by using a JEOL 100CX transmission electron microscope. 
DLS experiments were performed by using a Malvern Zetasizer (Nano series, Malvern 
Instruments Inc, USA). Flow cytometry analysis was performed in a BD LSR-II flow 
cytometer equipped with FACSDiva (BD Sciences, USA) by counting 5000 events. 
 AuNP_HKRK15b and QD_DHLA17a were synthesized by following reported 
methods. To generate the QD-mCherry conjugates, QD_DHLA (6.26 μM, 24 μL) and 
mCherry (120 μM, 7.5 μL) were added to PBS (50 μL) for 15 min. The template drops 
were generated by using 1 μL of oil (mixture of linoleic acid and decanoic acid in a molar 
ratio= 1:1) mixed with the AuNP_HKRK solution (1 μM in 500 μL of 5 mM sodium 
phosphate buffer (pH 7.4)) and agitated by using an amalgamator at 5000 rpm for 100 s.16 
The template droplets (15 μL) were added to AuNP_HKRK solution (3 μM in 35 μL of 5 
mM sodium phosphate buffer (pH 7.4)) for 5 min to form NPSC. The concentration of 
NPSC was 0.64 nM, as calculated according to a reported method.16 Finally, QD-
mCherry conjugates were added to the NPSC solution for 10 min to form NPSC_QD-




 Genetic engineering manipulation and mCherry expression were done according 
to previously reported methods.25 To construct pQE80-6xHis-mCherry plasmid, mCherry 
gene was sub-cloned from pCHERRY3 plasmid (Addgene ID 24659)26 into Bam HI and 
Hind III (downstream of 6xHis tag) restriction sites of pQE80 expression vector. To 
produce recombinant proteins, plasmid containing the respective genes were transformed 
into Escherichia coli BL21(DE3) strain. A transformed colony was picked up to grow 
small cultures in 50 mL 2xYT media at 37 ºC overnight. The following day, 15 mL of 
grown culture was inoculated into one liter 2xYT media and allowed to grow at 37 ºC 
until OD reaches 0.6 by using UV-Vis spectroscopy. At this point, mCherry expression 
was induced by adding isopropyl-b-D-thiogalactopyranoside (IPTG; 1 mM final 
concentration) at 25 ºC. After 16 h of induction, the cells were harvested and the pellets 
were lysed using a microfluidizer. His6-tagged mCherry were purified from the lysed 
supernatant using HisPur cobalt columns. The integrity and the expression of native 
protein were determined by a 12% SDS-PAGE gel and absorbance spectra. 
 The FRET titration of QD-mCherry conjugates was carried out in phosphate-
buffered saline (PBS). Varying amounts of mCherry were added to the QD_DHLA 
solution in a 96-well plate (300 µL, Whatman™ 96-well black UNIPLATE™ 
microplates), in which the final concentration of QDs was 100 nM and the total volume 
was 200 µL. After incubation for 15 min, fluorescence intensity was recorded on a 
Molecular Devices SpectraMax M5 microplate reader with excitation at 420 nm. 
 For the confocal microscopy studies, HeLa cells were cultured at 37 ºC under a 
humidified atmosphere of 5% CO2.The cells were grown in low-glucose Dulbecco’s 
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modified Eagle’s medium (DMEM, 1.0 g/L glucose) containing 10% fetal bovine serum 
(FBS) and 1% antibiotic (100 U/mL penicillin and 100 μg/mL streptomycin). The cells 
were maintained in the above medium and sub-cultured once every four days. HeLa cells 
were seeded (1.8×105 cells/dish) in glass-bottomed dishes (MatTek Corporation, 14 mm 
microwell) 24 h prior to the experiment. On the next day, the old media was removed and 
cells were washed with cold PBS. Then, the NPSC_QD-mCherry solution (131.5 μL of 
the NPSC_QD-mCherry complexes diluted by 1368.5 μL of the 10% serum-
supplemented media) and other control samples (mCherry and QD-mCherry conjugates) 
were added to the cells and incubated for 1 h. Final concentration of each component: 
QD= 100 nM, mCherry= 600 nM, NPSC= 0.021 nM. Thereafter, cells were washed with 
PBS three times before taking the images. Confocal microscopy images were obtained on 
a Zeiss LSM 510 Meta microscope by using a 63× objective. The settings of the confocal 
microscope were as follows unless otherwise specified: green channel of QD: λex= 488 
nm and λem= BP 505-530 nm; red channel of mCherry: λex= 543 nm and λem= LP 650 nm.  
 To analyze the fluorescence signal distribution, the straight lines or single cells in 
the confocal images were marked and the distribution of the gray values (or fluorescence 
values) of all pixels of the line/cell was calculated by using ImageJ software. The gray 
values corresponding to the fluorescence signal strength range from 0 (no signal) to 255 
(strong signal). We have analyzed 10-15 single cell samples for each set of experiments 
to obtain the ratio of cytosolic pixel counts to endosomal/lysosomal pixel counts of the 
intracellular mCherry.  
 In the experiment of chloroquine encapsulation in NPSC structure, chloroquine 
diphosphate salt was first dissolved in sodium bicarbonate solution and then extracted 
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into dichloromethane. The solvent was evaporated under vacuum to obtain the desalted 
chloroquine as a white powder. The desalted chloroquine was dissolved in oil at a final 
concentration of 100 mM for the template droplet formation, and the concentration of 
chloroquine in the media was 2 µM when delivering NPSC-CQ_QD-mCherry into the 
cells. The rest of the steps followed the general procedure of NPSC preparation. 
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CHAPTER 7 
INSULIN-BASED REGULATION OF GLUCOSE-FUNCTIONALIZED 
NANOPARTICLE UPTAKE IN MUSCLE CELLS 
7.1 Introduction 
Regulating cellular uptake of nanoparticle (NP) in biological systems is critical for the 
development of NP-based therapeutics. NP delivery vehicles can increase delivered doses 
of drugs and imaging agents, while diminishing undesired off-target effects. NPs with 
tailorable structures provide a potential means of controlling therapeutic efficacy1 as well 
as concomitant toxicity.2 For example, the surface charge and hydrophobicity of NPs 
determine their cellular uptake, facilitating the NP-assisted intracellular delivery3 and 
bioimaging.4 In particular, targeting motifs on NP surface can effectively guide them to 
cells through membrane protein recognition, providing receptor/transporter-mediated 
cellular uptake5 that can be modulated by external chemicals or biomolecules.6 
Glycomaterials are important nanoplatforms in biomedical applications,7 where 
the carbohydrate motifs allow these materials to be solubilized under physiological 
conditions 8  and recognized by cell membrane proteins. 9  For examples, galactose-
functionalized NPs can be selectively accumulated in hepatocellular carcinoma cell line 
HepG2 that expresses asialoglycoprotein receptor (ASGP-R).10 Also, 2-deoxyglucose-
functionalized NPs can target mammary tumor cells11 and migrate across the blood brain 
barrier 12  where glucose transporters (GLUTs) are highly expressed. The use of 
carbohydrate-functionalized NPs for active targeting depends on the level of receptors 
and transporters that are in a state of flux, providing a potential strategy to control the 
cellular uptake of carbohydrate-functionalized NPs through modulation of ASGP13 and 
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7.2 Results and discussion 
Glucose-conjugated ligands presenting dithiol anchoring groups were synthesized for the 
surface functionalization of QDs featuring 1) dihydrolipoic acid (DHLA) as a stable 
bidentate anchor,15 2) a tetra(ethylene glycol) (TEG) spacer to minimize non-specific 
interactions with proteins and cells,16 and 3) a glucose headgroup conjugated to the ligand 
through azide-alkyne cycloaddtion “click chemistry” (Figure 7.1a). CdSe/ZnS core-shell 
QDs were used to prepare glucose-functionalized QDs (Glc-QDs) through a ligand 
exchange process. The emission peak of Glc-QDs was observed at 555 nm and the 
dynamic light scattering (DLS) data showed that the hydrodynamic size of Glc-QDs was 
ca. 8 nm. 
The regulation of Glc-QD uptake was investigated in C2C12 cells, a widely used 
skeletal muscle cell line. It is well-established that insulin stimulates the GLUT4 
translocations from intracellular storage compartments to cell membrane to enhance the 
glucose uptake in C2C12 cells.17 Both non-differentiated and differentiated cells were 
cultured for Glc-QD uptake studies through choice of culture media. The morphology of 
C2C12 cells was changed from spindle-shaped myoblasts (Figure 7.2a) to fiber-shaped 
myotubes (Figure 7.2b) after differentiation. 18  The cellular uptake and intracellular 
distribution of Glc-QDs can be visualized using confocal microscopy. Glc-QDs were 
internalized and punctate fluorescence observed in the confocal images, consistent with 
the expected entrapment of Glc-QDs in endosomal/lysosomal compartments after cellular 
uptake.19 In parallel, the cytotoxicity of Glc-QDs was determined through alamarBlue® 
assay, where the results showed no significant toxicity was observed up to 1 µM of Glc-
QDs in both non-differentiated and differentiated cells after incubation for 4 h (Figure 








































 7.4a and 7.
ntiated cells
 been repor












 under the i
ted that GL
                   115
c-QDs (250












             




















d cells in 
































































ue to the 
dicated the
D uptake c


































































































































                   
onic fibrob
ce distribut





 of QDs use
-regulation 
 (2-DG), a g
ll. 22  In the 
ifferentiate






lls for 4 h 
fibroblast c











ells for 4 
periments w
 uptake wa
og that has b
f 2-DG, gr
ure 7.6). A





















































































                   











se in the intr
ntal section











 in C2C12 c
the glucose
eans of mo
Ds can be u
e of 2-DG.













e of 2-DG 













             
ed by GLU
 of Glc-QDs






























































                                                                                            
 
119
scattering (DLS) measurement was performed using a Malvern Zetasizer (Nano Series, 
Malvern Instruments Inc., USA), and the data analysis was done using Malvern PCS 
software. Flow cytometry analysis was performed in a BD LSR-II flow cytometer 
equipped with FACSDiva (BD Sciences, USA) by counting 10000 events, and the cell 
debris were excluded from analysis by proper dot plot gating. 
 QDs were decorated with glucose-functionalized ligands by following the 
reported two-step procedure.15 In the first step, trioctylphosphine oxide/trioctylphosphine 
(TOPO/TOP) coated QDs (10 mg) were mixed with HS-C5-TEG ligands (30 mg) in 
methanol (MeOH, 5 ml). The reaction mixture was stirred at 35 ºC for 24 h under inert 
atmosphere. In this step, amphiphilic ligands replaced the native hydrophobic ligands 
from the surface of QDs, and the resulting amphiphilic QDs became soluble in MeOH. 
Next step involved the purification of QDs with hexane and addition of glucose-
functionalized ligands (30 mg) to the amphiphilic QDs in MeOH. As a result, dithiol 
ligands slowly substituted monothiol ligands from QDs surface due to its better chelating 
capability. After 24 h of stirring, MeOH was evaporated and QDs were dispersed in 
water. Finally the aqueous QD sample was purified by dialysis. Gal-QDs were prepared 
by following the same procedure as Glc-QDs. The syntheses of PEG-QDs and TMA-QDs 
were followed the reported literatures. 23,15 
 C2C12 muscle cells and NIH/3T3 fibroblast cells (American Type Culture 
Collection (ATCC)) were cultured at 37 °C, 5% CO2 in a humidified atmosphere. C2C12 
cells were grown in the high glucose Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 10% fetal bovine serum and 1% antibiotics (100 U/mL penicillin and 
100 mg/mL streptomycin). NIH/3T3 cells were grown in the high glucose DMEM 
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supplemented with 10% bovine calf serum and 1% antibiotics. Differentiation of C2C12 
cells was followed the reported procedure.24  Briefly, cells were transferred to a 24-well 
plate (6×104 cells/well) and incubated for 48 h in growth media to about 100% 
confluence and then switched to differentiation media. Differentiation media was 
prepared in low glucose DMEM supplemented with 2% horse serum and 1% antibiotics. 
The differentiation media was changed when significant amount of cell death/floating or 
cell debris was present. Large multinucleated myotubes would be visible after C2C12 
cells were cultured in differentiation media for 4 days. 
 In the confocal microscopy studies of Glc-QDs in C2C12 cells, C2C12 cells were 
seeded in glass-bottomed dishes (1.8×105 cells/dish, MatTek Corporation, 14 mm 
microwell) 24 h prior to the confocal experiment. On the next day, the old media was 
removed and cells were washed with cold phosphate buffered saline (PBS). Glc-QD 
solution (250 nM in low glucose DMEM) was incubated with cells for 4 h. Thereafter, 
cells were washed with PBS three times before taking the images. Confocal microscopy 
images were obtained on a Zeiss LSM 510 Meta microscope by using a 63× objective. 
Settings of the confocal microscope: green channel of QD: λex= 488 nm and λem= BP 
505-550 nm (BP: band pass). 
 Cytotoxicity was determined by an alamarBlue® assay (Invitrogen Biosource, 
USA), which is based on the conversion of resazurin to resorufin via a reduction reaction 
dependent on cellular metabolic activity.25  Non-differentiated and differentiated cells 
were cultured in a 24-well plate (6×104 cells/well). The cells were incubated with Glc-
QD solutions (various concentrations in low glucose DMEM) for 4 h. After incubation, 
cells were washed with PBS and treated with 10% alamarBlue® dye in low glucose 
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addition of 2-propynol (1.5 mmol). After 4 h at room temperature, the reaction was 
quenched with saturated NaHCO3 solution. The product was purified by chromatography 
column with EtOAc/Hexane as eluent (1:1, v:v) in 81% yield. 
1H NMR (400 MHz, CD3OD): 5.23 (t, 1H,  H-3), 5.09 (t, 1H, H-4), 5.00 (t, 1H, H-2), 
4.75 (d, 1H, H-1), 4.35 (d, 2H, OCH2CCH), 4.27 (m, 1H, H-6), 4.14 (dd, 1H, H-6´), 3.73 
(m, 1H, H-5), 2, 47 (t, 1H, OCH2CCH), 2.08 (s, 3H, OAc), 2.05 (s, 3H, OAc), 2.02 (s, 
3H, OAc), 2.00 (s, 3H, OAc) ppm.  
Compound 2: Thioctic acid (2.56 g, 12.4 mmol) was dissolved in 75 ml dry DCM and 
cooled to 0 oC for 5 min. EDC (2.78 g, 14.5 mmol), HOBt (1.9 g, 12.4 mmol) and DIPEA 
(1.603 g, 12.4 mmol) were added to the solution, and the solution was purged with N2 gas 
for several min. Amino terminated tetraethylene glycol (2 g, 10.3 mmol) was added to the 
reaction mixture and stirred at r.t. for 24 h. Then, the reaction mixture was diluted with 
DCM, filtered with Celite, and washed with brine and water. Compound 2 was obtained 
by using column chromatography with 100 % EtOAc as eluent in 51% yield. 
1H NMR (400 MHz, CD3OD) major peaks assigned: 3.73 (t, 2H, CH2CH2OH), 3.71-3.51 
(m, 12H, TEG), δ 3.46 (t, 2H, CONHCH2CH2), 3.21-3.08 (brm, 2H), 2.51-2.42 (brm, 
1H), 2.19 (t, 2H, CH2CH2CONH), 1.76-1.62 (m, 4H), 1.52-1.40 (m, 2H) ppm. 
Compound 3: Compound 2 was dissolved in 50 ml of dry THF, and cooled to 0 oC in ice 
bath. NEt3 and CH3SO2Cl was added to the solution under stirring condition at 0 oC. The 
reaction was stirred overnight at r.t. Then, the reaction mixture was diluted with THF and 
washed with 5 % HCl, NaHCO3 and water. After removing THF, the reaction mixture 
was redissovled in 20 ml of DMF/EtOH (30:70. v:v), and NaN3 was added at 80 oC. 
Finally, the mixture was heated to 90 oC for overnight. Compound 3 was obtained by 
using column chromatography with MeOH/EtOAc (1:10, v:v) as eluent in 92% yield. 
1H NMR (400 MHz, CD3OD) major peaks assigned: 3.68 (t, 2H, CH2CH2OH), 3.65-3.42 
(m, 12H, TEG), 3.40 (t, 2H, CONHCH2CH2), 3.21-3.08 (brm, 2H), 2.51-2.42 (brm, 1H), 
2.19 (t, 2H, CH2CH2CONH), 1.76-1.61 (m, 4H), 1.52-1.41 (m, 2H) ppm. 
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Compound 4: A solution of 3 (300 mg, 0.74 mmol) and 1 (313 mg, 0.81 mmol) in 5 ml of 
DCM was added to another solution of CuSO4 (17.7 mg, 0.11 mmol) and sodium 
ascorbate (66 mg, 0.33 mmol) in 5 ml of water. The reaction mixture was stirred at r.t. for 
24 h. The aqueous and organic phases were separated when the stirring was stopped. The 
aqueous layer was washed with DCM (3 × 10 mL) and the organic layer was dried with 
NaSO4. The product was purified by chromatography column with MeOH/EtOAc (1:10, 
v:v) as eluent in 77% yield. 
1H NMR (400 MHz, CD3OD): 7.73 (s, 1H, CCHN), 5.19 (t, 1H,  H-3), 5.10 (t, 1H, H-4), 
5.00 (t, 1H, H-2), 4.92 (d, 1H, OCH2CNCH2), 4.83 (d, 1H, OCH2CNCH2), 4.70 (d, 1H, 
H-1), 4.59-4.52 (m, 2H, NCH2CH2O), 4.27 (dd, 1H, H-6), 4.13 (dd, 1H, H-6´), 3.89 (t, 
2H, NCH2CH2O), 3.78 - 3.52 (m, 12H, TEG), 3.45 (t, 2H, CONHCH2CH2), 3.22-3.08 
(brm, 2H), 2.51-2.42 (brm, 1H), 2.19 (t, 2H, CH2CH2CONH), 1.74-1.61 (m, 4H), 1.53-
1.39 (m, 2H) ppm. 
Compound 5: NaOMe (123 µl, 0.63 mmol) was added to a solution of 4 (500 mg, 0.63 
mmol) in dry and deoxygenated MeOH (5 ml). After 5 min, the reaction mixture was 
neutralized with +H Dowex resin, filtered with Millex-GP syringe filter (0.22 µm), and 
the solvent was evaporated. The mixture (0.5 g) was dissolved in 10 ml of EtOH / water 
(1:4) with stirring, and NaBH4 (0.075 g) was added to the solution. The reaction mixture 
was stirred for 1 h and became colorless. The reaction mixture was diluted with water and 
extracted with CHCl3. The combined organic phase was dried over Na2SO4. Compound 5 
can be obtained after evaporating the solvent.  
1H NMR (400 MHz, CD3OD): 8.07 (s, 1H, click), 5.0 (t, 1H,  H-3), 4.8 (t, 1H, J = 10 Hz, 
H-4), 4.58 (m, 2H, NCH2CH2O), 4.40 (dd, 1H, H-6), 4.13 (dd, 1H, H-6´), 3.89 (t, 2H, 
NCH2CH2O), 3.70-3.48 (m, 12H, TEG), 3.31 (t, 2H, CONHCH2CH2), 3.23-3.07 (brm, 
2H), 2.51-2.41 (brm, 1H), 2.20 (t, 2H, CH2CH2CONH), 1.77-1.55 (m, 4H), 1.53-1.36 (m, 
2H) ppm. 
MS (ESI-MS) calculated for C25H46N4O10S2 626.27, found 647.59 [M-Na] and 663.60 
[M-K] 
The synthesis of galactose-functionalized ligand was followed the same procedure as 
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glucose-functionalized ligand while using β-D-galactose pentaacetate as a starting 
material.  
1H NMR (400 MHz, CD3OD): 8.11 (s, 1H, click), 4.90 (t, 1H,  H-3), 4.77 (t, 1H, J = 10 
Hz, H-4), 4.64 (m, 2H, NCH2CH2O), 4.47 (dd, 1H, H-6), 3.97 (dd, 1H, H-6), 3.90 (t, 2H, 
NCH2CH2O), 3.84-3.50 (m, 12H, TEG), 3.33 (t, 2H, CONHCH2CH2), 3.27-3.11 (brm, 
2H), 2.52-2.40 (brm, 1H), 2.23 (t, 2H, CH2CH2CONH), 1.67-1.51 (m, 4H), 1.46-1.30 (m, 
2H) ppm. 
MS (ESI-MS) calculated for C25H46N4O10S2 626.27, found 647.69 [M-Na] and 663.70 
[M-K] 
Abbreviations:  
1-Ethyl-3-(3-dimethyllaminopropyl)carbodiimide (EDC), hydroxybenzotriazole (HOBt), 
N,N-diisopropylethylamine (DIPEA), and mesyl chloride (MsCl), dichloromethane 
(DCM), dimethylformamide (DMF), tetra-ethylene glycol (TEG). 
The electrospray ionization mass spectrometry (ESI-MS) was acquired at positive 
mode on a Bruker Esquire-LC (Billerica, MA) quadrupole ion trap mass spectrometer, 
equipped with an electrospray ionization source. The electrospray needle voltage was set 
to 3.5 kV, and the capillary temperature was kept as 300 ºC. Usually a voltage of 30 V 
was applied to skimmer 1 and a voltage of 80 - 90 V was applied to the capillary offset. 
Samples (~20 µM) were delivered at 200 µL/h using a syringe pump. 
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CHAPTER 8 
FABRICATION OF FUNCTIONAL NANOFIBERS THROUGH POST-
NANOPARTICLE FUNCTIONALIZATION 
8.1 Introduction 
Engineering the surface functionality of nanofibers provides potential applications in 
materials science (e.g., textiles1 and solar cells2) and biomedicine (e.g., biosensor3 and 
drug delivery4). Strategies to modify the nanofiber surface involve plasma treatment,5 co-
electrospinning, 6  wet chemistry 7  and surface graft polymerization 8 . However, these 
methods have limitations in terms of functional group density, where the plasma 
treatment cannot effectively modify the surface of buried nanofibers5, 9  and grafting 
polymer on the nanofiber surface usually generates low density of functional groups10. In 
addition, these methods also lack the ability to provide secondary property (e.g., 
magnetism and photoluminescence) to nanofibers.  
Integration of nanoparticles (NPs) into nanofibers is a promising approach to 
increase the coverage of functional groups and generate versatile nanofibers with desired 
properties. The large surface area-to-volume ratio allows the NP surface to be coated with 
dense molecules to provide high density coverage of functional groups on nanofiber 
surface. Through the appropriate choice of NP core, NPs can incorporate their unique 
physicochemical properties to nanofibers such as magnetic11 and fluorescent12 properties.  
NPs can be introduced to the nanofiber structure through direct synthesis and 
assembly of NPs, 13  covalent conjugation 14  and supramolecular interactions (e.g., 
hydrogen-bonding15 and electrostatic interactions16), while most of the interactions are 
labile and can be interrupted by pH and temperature. In addition, several challenges of 
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NP-nanofiber composites still need to be addressed, including control over the size, 
stability and distribution of NPs in the composites. Dithiocarbamate (DTC) chemistry 
provides an alternative fabrication strategy that addresses the construction challenges of 
NP-nanofiber composites through N-C-S2 group formation to generate stable self-
assembled NPs on nanofibers. DTC chemistry has been employed widely to stabilize 
ligands on gold/semiconductor NP surface. 17  Furthermore, NPs with different 
functionalities can be immobilized on the surface through DTC-based process, with high 
stability in organic solvent and buffer solution.18 
 Here we present a facile approach to fabricate functional nanofibers through post-
NP functionalization using DTC chemistry, where NPs were used as “paint” to provide 
dense and diverse functional groups on nanofiber surface. In the NP-nanofiber 
composites, amine-functionalized nanofibers were activated in the presence of CS2 to 
generate DTC groups on the nanofiber surface, allowing the immobilization of gold NPs 
(AuNPs) and quantum dots (QDs) (Figure 8.1). The resulting NP-nanofiber composites 
were characterized by electron microscopy and energy dispersive X-ray spectroscopy. 
Furthermore, the functional nanofibers presented antibacterial activity and fluorescent 
property with the effective coating of AuNPs and QDs, respectively. This post-NP 
functionalization approach is simple and reliable to provide a monolayer of NPs on 
nanofibers for different applications. 
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microscopy (TEM) and energy-dispersive X-ray spectroscopy (EDS). Nanofibers 
exhibited submicron fiber diameters (~ 0.45 μm) with cylindrical morphologies and 
smooth surfaces as observed via SEM (Figure 8.2a). However, the smoothness of the 
nanofiber surface decreased after the functionalization with AuNP-TTMA (Figure 8.2b). 
The changes in surface structural features were due to the self-assembly of NPs on 
nanofiber surface through DTC chemistry. AuNP-nanofiber composites were further 
characterized using TEM, where AuNPs on the nanofibers were correspond to the dark 
spots in the bright field TEM image. AuNPs were observed on the nanofibers under the 
CS2 activation (Figure 8.2c and 8.2d) while very few AuNPs were shown in the absence 
of CS2 (Figure 8.2e and 8.2f). The immobilization of AuNPs on the nanofibers was 
further investigated by EDS analysis (Figure 8.3). The EDS spectrum showed the 
compositions of C, N, O, Si, S and Au in the AuNP-nanofiber composites. A significant 
amount of S and Au was detected in the composites, indicating the effective coating of 
AuNP on nanofibers through DTC-based process. 
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and (d), fluorescence images of QD (λex= 458 nm, λem= BP 505-530 nm), mCherry (λex= 
543 nm, λem= LP 585 nm) and FRET signals (λex= 458 nm, λem= LP 585 nm) were 
shown. Emission filters: BP= band pass, LP= high pass. 
8.3 Conclusion 
We have demonstrated a versatile approach to functionalize the surface of nanofibers by 
the coating of NPs through DTC chemistry. This method allows the fabrication of a 
homogenous monolayer of NPs on nanofiber surface, providing the dense functional 
groups and the inherent unique properties of NPs to nanofibers. This effective surface 
modification strategy provides a potentiality to create multifunctional nanofibers to 
achieve multiple objectives in biological and materials applications. In addition, the 
fabrication of protein-NP hybrid bionanostructure on nanofibers presents a potential rout 
to construct novel hybrid materials and devices.  
8.4 Experimental section 
All chemicals used for the fabrication of NPs were purchased from Sigma-Aldrich, Fisher 
Scientific or Stream, unless otherwise specified. The chemicals were used as received. 
Dichloromethane (DCM) used as solvent for chemical synthesis was dried according to 
standard procedure. 
Each specimen was dehydrated by immersing in 100% ethanol for 30 min, 
infiltrated with N-butylglycidylether and finally embedded in epoxy resin. Then the 
specimens were sliced to 50-100 nm thickness using Ultramicrotome EM UC7 (Leica, 
Wien, Austria). The electro spinning fibers were observed under transmission electron 
microscopy (TEM; Tecnai G2, FEI, Hillsboro, OR, USA) at 120 kV. Bright field TEM, 
high-angle annular dark field scanning transmission electron microscopy (HAADF-
STEM), and scanning transmission electron microscopy elemental mapping energy-
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dispersive X-ray spectroscopy analysis (STEM-EDS) were performed using Tecnai Osiris 
(FEI, Hillsboro, OR, USA) at 200 kV.  
In the synthesis of nanofibers, 5% (w/w) polycaprolactone (PCL) (Mn 70,000-
90,000; Sigma-Aldrich, St. Louis, MO) and 1.0% (w/w) N-[3-(Trimethoxysilyl)propyl] 
ethylenediamine (TMSPEDA) solutions were prepared by blending at a 1:1 ratio in 
1,1,1,3,3,3-hexafluoro-2-propanol (HFP) (>99% purity; Sigma-Aldrich, St. Louis, MO) 
by stirring at room temperature for 24 h. Blended PCL-TMSPEDA solutions were then 
poured individually into separate 20 cc syringes, fitted with a 20 gauge blunt-tipped 
needle, and electrospun using a DC high voltage power supply (Glassman High Voltage, 
Inc., High Bridge, NJ) at positive 25 kV, 20 cm needle-to-collector distance, 15 mL/h 
flow rate, for 10 min at an average relative humidity of 30%. These nanofibers were 
deposited onto the aluminum foil for the given time frame at a flow rate of 10 mL/min. 
The fiber density of the matrix is 15% solid material (i.e. fiber) and 85% void spaces (i.e. 
inter-fiber pores). 
The syntheses of AuNP-TTMA and AuNP-C10 were followed the reported 
literatures with some modification.23 Briefly, AuNPs protected with 1-pentanethiol (C5) 
and arginine-terminated thiol ligands were prepared following the reported procedure.24 
NPs functionalized with arginine moiety were prepared following the ligand exchange 
procedure.25 In a typical reaction, 10 mg of C5-protected NPs was first dissolved in 1 mL 
of dry dichloromethane (DCM). TTMA (or C10)-terminated thiol ligands (40 mg) were 
dissolved in 5 mL of organic solvent (DCM : MeOH = 4 : 1 v/v), and then added to the 
solution of C5-protected NPs. The reaction mixture was stirred at room temperature for 3 
days. Finally, the organic solvent was evaporated and NPs were dissolved in MilliQ 
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water. The aqueous solution of NPs was purified by dialysis for 3 days. 
The synthesis of QD-TTMA was followed the reported literatures with some 
modification.21 Basically, hydrophobic CdSe/ZnS core-shell QDs were synthesized 
according to the reported procedure26 and the preparation of QD-TTMA was through 
ligand exchange process with slight modification21. TTMA-terminated thiol ligands were 
placed in MeOH under ligand to QD ratio by weight (7: 1), and the solution was stirred at 
37 ºC for 4 days. The aqueous QD-TTMA solution was purified by dialysis. 
In the fabrication of NPs on nanofibers, NPs (i.e. AuNP-TTMA, AuNP-C10 and 
QD-TTMA) were prepared in methanol (7 µM in 1 mL), and triethylamine (TEA, 33 µL) 
was added to the solution. The mixture was sonicated for 1 min and filtered using a 
syringe filter (diameter: 25 mm; porosity: 0.22 µm; materials: PTFE 
(polytetrafluoroethylene)). The nanofiber samples (0.3 cm × 1 cm of aluminum foil) were 
immersed in the methanol (600 µL), and CS2 (20 µL) was added to the solution. The 
mixture was sonicated for 30 sec - 1 min. After the sonication, the nanofiber samples 
were under the CS2 activation for 5 min. After the activation, AuNP-C10 solution (600 
µL) was added to the nanofiber immersed solution for a 30 min incubation. The nanofiber 
samples were washed with methanol, ethanol and finally dried under the nitrogen flow. 
In the experiment of antibacterial activity, bacteria (E. coli) were cultured in 
Luria-Bertani (LB) broth at 37 ºC till stationary phase and then were centrifuged and 
washed with 0.85% NaCl solution for three times. The pellets were re-suspended in 
phosphate buffer saline (PBS) and the concentration was determined by optical density 
(OD) at 600 nm. Solutions containing bacteria at OD600 ~ 0.1 were made in PBS for 
antimicrobial surface studies. In general, AuNP-nanofiber composites on the aluminum 
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foil were submerged in bacteria solution and incubated for 3 h at room temperature 
followed by gentle wash. After washing, the surfaces were then put into dye mixture 
solutions made from the LIVE/DEAD BacLight Bacterial Viability Kit and kept in dark 
for 10 min before imaging. Confocal laser scanning microscopy (Zeiss 510 META) was 
employed to image the stained surfaces. All images were taken at 488/543 nm excitation 
wavelength, and emission band pass 505-550 nm was chosen for green fluorescence 
channel and emission band pass 585-615 nm was chosen for red fluorescence channel. 
After obtaining images, they were processed in ImageJ to count live and dead bacterial 
cell numbers. Number of both green (live bacteria) and red bacteria (dead bacteria) was 
considered to be the total bacteria number, and the bacterial cell viability was calculated 
following: 
Viability (%) = (Number of green bacteria / Total number of bacteria) × 100%.  
For each surface, six images at different spots were taken and calculated for viability. 
Hemolysis assay was performed based on the reported procedure. 27  Citrate-
stabilized human whole blood (pooled, mixed gender) was purchased from 
Bioreclamation LLC, NY and processed as soon as received. 10 mL of PBS was added to 
the blood and centrifuged at 5000 r.p.m. for 5 min. The supernant was carefully discarded 
and the red blood cells (RBCs) were dispersed in 10 mL of PBS. This step was repeated 
at least five times. The purified RBCs were diluted in 10 mL of PBS and kept on ice 
during the sample preparation. 0.1 mL of RBC solution was added to 0.4 mL of PBS, and 
the nanofiber samples were immersed in the solution. RBCs incubated with PBS and 
water were used as negative and positive control, respectively. All nanofiber samples and 
controls were prepared in triplicate. The mixture was incubated at 37 ºC for 30 min while 
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shaking at 150 r.p.m. After incubation period, the solution was centrifuged at 4000 r.p.m. 
for 5 min and 100 μL of supernatant was transferred to a 96-well plate. The absorbance 
value of the supernatant was measured at 570 nm using a microplate reader (SpectraMax 
M2, Molecular Device Inc., USA) with absorbance at 655 nm as a reference.  
Genetic engineering manipulation and mCherry expression were done according 
to previously reported methods.28 To construct pQE80-6xHis-mCherry plasmid, mCherry 
gene was sub-cloned from pCHERRY3 plasmid (Addgene ID 24659)29 into Bam HI and 
Hind III (downstream of 6xHis tag) restriction sites of pQE80 expression vector. To 
produce recombinant proteins, plasmid containing the respective genes were transformed 
into Escherichia coli BL21(DE3) strain. A transformed colony was picked up to grow 
small cultures in 50 mL 2xYT media at 37 ºC overnight. The following day, 15 mL of 
grown culture was inoculated into one liter 2xYT media and allowed to grow at 37 ºC 
until OD reaches 0.6 by using UV-Vis spectroscopy. At this point, mCherry expression 
was induced by adding isopropyl-b-D-thiogalactopyranoside (IPTG; 1 mM final 
concentration) at 25 ºC. After 16 h of induction, the cells were harvested and the pellets 
were lysed using a microfluidizer. His6-tagged mCherry were purified from the lysed 
supernatant using HisPur cobalt columns. The integrity and the expression of native 
protein were determined by a 12% SDS-PAGE gel and absorbance spectra. 
Confocal microscopy images were obtained on a Zeiss LSM 510 Meta 
microscope by using a 10× objective. The settings of the confocal microscope were as 
follows unless otherwise specified: green channel of QD: λex= 488 nm and λem= BP 505-
530 nm; red channel of mCherry: λex= 543 nm and λem= LP 585 nm.  
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CHAPTER 9 
SUPRAMOLECULAR TAILORING OF PROTEIN-NANOPARTICLE 
INTERACTIONS USING CUCURBITURIL MEDIATORS 
9.1 Introduction 
Nanoparticles (NPs) provide tailorable surface chemistries that allow facile modulation of 
protein-NP interactions.1 These interactions are useful tools for modulating enzymatic 
activity, 2  delivering proteins 3  and sensing cancerous cells. 4  Furthermore, regulating 
protein-NP assemblies offers an effective route to construct novel hybrid materials and 
devices.5  
Supramolecular host-guest chemistry provides an alternative to covalent 
approaches6 to modulate NP surface functionality.7 The properties of monolayers on NP 
surface can be efficiently tailored through the complexation with guest molecules, where 
the physicochemical properties (e.g., hydrophobicity and charge) of the guest molecules 
are imparted to the NP surface. In reported studies, tailored surface charge, 8 
hydrophilicity/phobicity9 and redox potential10 of NPs have been achieved through the 
reversible threading/dethreading of the guest molecules on the NP surface. This 
supramolecular tailoring approach provides an important “post-synthetic” strategy for 
surface modification of NPs to regulate molecular recognition and binding strength of the 
target molecules.8   
We report here the use of supramolecular host-guest chemistry to modulate 
protein-NP interactions through control of the hydrophilicity/phobicity of the NP surface. 
Gold nanoparticles (AuNPs) functionalized with a diaminohexane motif were modified 
using cucurbit[7]uril (CB[7])11 to form pseudorotaxane structures (Figure 9.1a). Binding 
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charged AuNPs, with concomitant fluorescence quenching by AuNPs.4 From the 
fluorescence titrations, it was clear that the fluorescence intensity of GFP decreased upon 
the addition of NPs, where NP2 displayed more efficient quenching ability (Figure 9.3a). 
The higher quenching efficacy of NP2 was expected based on the higher number of 
cationic ligands available to electrostatically bind to GFP surface. These results were 
consistent with the reported studies demonstrating that the particles with higher cationic 
ligand coverage can interact more strongly with proteins.18 
To investigate the effect of CB[7] on the GFP-NP complexations, CB[7]-threaded 
NPs (NP/CB[7]) were prepared with varying CB[7] to NP ratios. When the NP/CB[7] 
complexes were titrated with GFP, the particles quenched the fluorescence of GFP in a 
CB[7] concentration-dependent manner (Figure 9.3b and 9.3c). The binding parameters 
such as binding constant (Ks) and binding stoichiometry (n) of the GFP-NP conjugates 
were determined through nonlinear least-squares curve-fitting of the titration data.19 The 
correlation plots of Ks and n of GFP-NP and the corresponding GFP-NP/CB[7] 
complexes were shown in Fig. 9.4. Both the Ks and n values of GFP-NP/CB[7] 
complexes were higher compared to that of GFP-NP complexes, indicating that the 
NPs/CB[7] presented an increased protein binding affinity as well as the amount of 
protein bound. This CB[7]-responsive binding behavior of GFP-NP complexes were 
further confirmed by the higher fluorescence quenching with increasing CB[7] amounts 
at a fixed GFP:NP1 ratio (4:1) (Figure 9.3d). Taken together, the NP/CB[7] complexes 
exhibited a greater GFP binding efficiency than the NPs only. In addition, controlling the 
amount of CB[7] enabled the tuning of protein-NP interactions.  
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the self-assembled monolayers (SAMs)26 and protein adsorption27 on NP surface. The 
addition of CB[7] to the NPs with different curvature may affect the SAMs and regulate 
the protein-NP interactions. The role of NP curvature along with CB[7] molecules on the 
SAMs and protein adsorption could be further investigated using computational 
stimulation28 and analytical tools. 13 
9.3 Conclusion 
We have demonstrated that protein-NP interactions can be efficiently tailored by 
threading different amounts of CB[7] on NP surface. We showed that supramolecular 
host-guest chemistry provided a simple and straightforward method to modulate the 
surface properties of NPs and concomitantly regulate the protein-NP interactions. Taken 
together, this supramolecular tailoring approach can open new possibilities to effectively 
control protein stabilization for biotechnology and delivery applications. 
9.4 Experimental section 
Gold nanoparticles (AuNPs) protected with 1-pentanethiol (C5) and diaminohexane-
terminated thiol ligands (DAH) were prepared following the reported procedure.12,13 NPs 
functionalized with DAH moiety were prepared following the ligand exchange 
procedure.14 In a typical reaction, 10 mg of C5 functionalized NP (NPC5) was first 
dissolved in 1 mL of dry dichloromethane (DCM). DAH ligands (10 mg for NP1 and 40 
mg for NP2) were dissolved in 5 mL of organic solvent (DCM:MeOH (4:1 v/v)), and then 
added to the solution of NPC5. The reaction mixture was stirred at room temperature for 
48 h. After 48 h, the organic solvent was evaporated and NPs were dissolved in MilliQ 
water. The aqueous solution of the NPs was purified by dialysis. 
 Genetic engineering manipulation and GFP expression were done according to 
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previously reported methods.29 To construct pQE80-6xHis-GFP plasmid, GFP gene was 
PCR amplified and cloned from pET21-d EGFP plasmid into BamHI and Hind III 
(downstream of 6xHis tag) restriction sites of pQE80 expression vector. To produce 
recombinant proteins, plasmid containing the respective gene was transformed into 
Escherichia coli BL21(DE3) strain. A transformed colony was picked up to grow small 
cultures in 50 mL 2xYT media at 37 ºC for overnight. The following day, 15 mL of 
grown culture was inoculated into one liter 2xYT media and allowed to grow at 37 ºC 
until OD reaches 0.6 by using UV-Vis spectroscopy. At this point, GFP expression was 
induced by adding isopropyl-b-D-thiogalactopyranoside (IPTG; 1 mM final 
concentration) at 25 ºC. After 16 h of induction, the cells were harvested and the pellets 
were lysed using microfluidizer. His-tagged GFP were purified from the lysed 
supernatant using HisPur cobalt columns. The integrity and the expression of native 
protein were determined by a 12% SDS-PAGE gel and absorbance spectra. 
 Both laser desorption/ionization mass spectrometry (LDI-MS) and matrix assisted 
laser desorption/ionization mass spectrometry (MALDI-MS) were performed at positive 
mode on a Bruker Autoflex III time-of-flight mass spectrometer (Autoflex III). All mass 
spectra were acquired in reflection mode. Operating conditions were as follows: ion 
source 1= 19.00 kV, ion source 2= 16.60 kV, lens voltage= 8.44 kV, reflector voltage= 
20.00 kV, and reflector voltage 2= 9.69 kV. For the LDI-MS experiments, 2.5 μL of NP 
solutions were applied to a metal sample target. After allowing it to dry, the LDI-MS 
analysis was performed. A saturated α-CHCA stock solution was prepared in 70 % 
acetonitrile, 30 % H2O and 0.1 % trifluoroacetic acid for the MALDI-MS analyses. This 
stock solution was added an equal volume of analyte solutions of the NP-CB[7] 
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complexes. 2.5 μL of this mixture was applied to target and allowed it to dry before the 
MALDI-MS analysis was performed.  
 GFP-NP complexations were carried out in sodium phosphate buffer (5 mM, pH 
7.4) using a 96-well plate. GFP (100 nM) was conjugated with various concentrations of 
NPs in a 96-well plate to produce a range of NP/GFP binding ratio from 0 to 1.6 (final 
volume for each well was 200 µL). After 30 min of conjugation, the fluorescence 
endpoint was measured with an excitation wavelength of 475 nm and recorded the 
fluorescence wavelength of 510 nm using a Molecular Devices SpectraMax M5 
microplate reader.  
For the ADA-CB[7] complexation, GFP-NP1, GFP-NP1/50CB[7] and GFP-
NP2/100CB[7] complexes were conjugated as described previously. After 30 min of 
conjugation, ADA was added to each well (final concentration of 100 µM) for another 15 
min before the fluorescence of GFP was measured. 
 TMA ligand was synthesized following the procedure reported.25c The ligand 
exchange process was similar as the preparation of NP1, where 10 mg of NPC5 and 10 
mg of TMA ligand were used in the reactions. 
 In the β-galactosidase (β-gal) activity assay studies, β-gal was purchased from 
Sigma-Aldrich and the colorgenic substrate chlorophenol-red-β-D-galactopyranside 
(CPRG) was purchased from Roche Applied Science. In this study, β-gal, nanoparticle 
and CPRG solutions were prepared in sodium phosphate buffer solution (5 mM, pH 7.4). 
In the activity assay studies, β-gal (1 nM) was conjugated with various concentrations of 
NPs in a 96-well plate, and the final volume for each well was 200 µL. After 30 min 
conjugation, CPRG was added for another 10 min (final concentration of CPRG was 1.5 
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mM). The enzymatic activity was determined by the product formation at absorbance 
wavelength of 595 nm using a Molecular Devices SpectraMax M5 microplate reader. 
Different chemical agents were used to interfere with the major interactions in the 
complexes. GFP-NP and GFP-NP/CB[7] complexes were conjugated in a 96-wells plate 
for 30 min before the adding of different chemical reagents with different final 
concentrations (i.e., NaCl (400 mM), Tween-20 (1%) and urea (400 mM)). After 
incubation with the chemical agents for another 15 min, the fluorescence of GFP was 
measured and analyzed. 
Different proteins were used to investigate the selective interactions between 
particles and proteins. GFP-NP1 and GFP-NP1/50CB[7] complexes (GFP:NP = 1:1, 200 
μL) were conjugated in a 96-wells plate for 30 min before the addition of protein 
solutions (10 μL of bovine serum albumin (BSA), lysozyme (Lys) and β-galactosidase (β-
gal)), where the final concentration of the protein was 100 nM. After 30 min incubation 
with protein, the fluorescence of GFP was measured and analyzed. 
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CHAPTER 10 
TEMPLATION OF NANOPARTICLE MONOLAYERS TO PROTEIN SURFACE 
THROUGH MOLECULAR RECOGNITION 
10.1 Introduction 
Protein-protein interactions are crucial in almost every biological process, including cell 
proliferation, growth and differentiation and many others. 1  The ability to modulate 
protein behavior and function via surface recognition with synthetic materials provides 
the potential to better understand biological events2 and develop improved therapeutics3. 
However, the design of synthetic systems for protein surface recognition remains difficult 
given the large interfacial area required for specific recognition as well as the unique 
topological distribution of charged and hydrophobic residues on protein surfaces. 4 
Monolayer-protected nanoparticles (MNPs) provide a multivalent scaffold for protein 
surface recognition by proper surface functionalization.5   Surface-functionalized NPs 
have been employed to modulate enzymatic activity, 6  quench the fluorescence of 
proteins 7  and deliver proteins into cells. 8  Nevertheless, rational design of surface-
functionalized NPs for specific and selective recognition of protein remains challenging.  
Templation of the NP monolayers to the surface of protein is a promising strategy 
to provide effective protein surface recognition. The mobility of the ligands that make up 
a given self-assembled NP monolayers offers an environmentally responsive system to 
interact with target molecules. Monolayers on NP surfaces can template to small 
molecules9 and peptides10 through surface recognition. In the case of peptides, templation 
was evident from the formation of a peptide helix that was readily measured. While this 
was a convenient means to monitor changes upon NP-peptide binding, it did not provide 
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direct evidence of the ligand migration on NP surface. Therefore, another method is 
needed to provide the direct detection of the monolayer reorganization on NP surface to 
validate the templation of NP monolayers to protein surfaces. 
We report here the templation of monolayers on NPs through protein surface 
recognition, and the readout of this monolayer rearrangement using laser 
desorption/ionization mass spectrometry (LDI-MS). LDI-MS is an approach in which the 
core of the NPs absorbs and transfers the laser energy to desorb and ionize the surface 
ligands. This ionization occurs only for ligands that are attached to the NP core, while 
other molecules (e.g., protein and free ligands) are not ionized and detected, which 
provides good potential to study the surface ligand of NPs.11 While other approaches 
have been used to characterize the molecular structure and monolayer organization on 
NPs,12 LDI-MS can provide information about mixed monolayers even when NPs are 
present in complex mixtures. Using this approach, we find that mixed monolayers on NP 
surfaces can be repositioned and templated through complementary electrostatic 
interactions with proteins. The extent of the templated NP monolayers was found to 
increase for longer complexation times and at lower salt concentrations and temperatures, 
indicating the monolayer templation can be fine-tuned through the control of 
environmental factors.   
10.2 Results and discussion 
Mixed monolayer-protected gold nanoparticles (MMNPs) featuring two functional 
groups, an anionic tetra(ethylene glycol)-carboxy group (TCOOH) and a neutral 
tetra(ethylene glycol)-hydroxy (TOH) group (Figure 10.1a), were prepared via ligand 
exchange. The ratio of these two functional groups on the MMNP surface was determined 
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by nuclear magnetic resonance (NMR), and the percentages of TCOOH and TOH on 
MMNPs were found to be about 70% and 30%, respectively. These MMNPs were further 
characterized using transmission electron microscopy (TEM) to reveal that the ligand 
exchange reaction did not cause particle aggregation and that the particle sizes were 2.2 ± 
0.3 nm. Dynamic light scattering (DLS) measurements show that the hydrodynamic 
diameter of the MMNPs are 8 ± 3 nm and have a zeta potential of -40 ± 15 mV, which is 
consistent with the excess of anionic groups on the surface of these particles.  
LDI-MS was used to measure the mixed monolayers on the NPs. For those NPs 
that use thiol chemistry to link to the NP core, the formation of disulfide ions in the mass 
spectrum indicates the presence of more than on ligand on the same NP core.13 This 
unique feature of LDI-MS makes it an excellent tool for characterizing monolayer 
distributions on NP surfaces. As an example, the LDI mass spectrum of the MMNP in 
Figure 1 reveals characteristic peaks for the TCOOH and TOH ligands and their fragment 
ions (Figure 10.1b). In addition, three disulfide ions (Di-TCOOH, TCOOH-TOH and Di-
TOH) are also apparent in the mass spectrum. As we demonstrated in previous work, 
such disulfide ions only arise from ligands that are close to one another on the NP’s 
surface.13 The peak intensity ratios of these disulfide ions can be used as indicators of the 
ligand distributions, and thus the ion intensity ratios P1 and P2 were used to monitor the 
proximity of the TCOOH and TOH ligands to one another (Figure 10.1d). A higher P1 
value indicates that the TCOOH ligands tend to cluster more closely to one another on the 
NP surface, while a higher P2 value indicates that the TCOOH and TOH ligands are more 
randomly distributed (Figure 10.1e).  For the example mass spectrum shown in Scheme 
10.1, the value for P1 is 0.6, while the value for P2 is 0.4. These values indicate that the 
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were prepared in 5 mM sodium phosphate buffer (pH 7.4) at a fixed ChT to MMNP ratio 
of 1, where the activity of ChT was inhibited by anionic MMNPs through electrostatic 
complex formation (Figure 10.2b and 10.2c). 16  The monolayer organization of the 
MMNPs was monitored by LDI-MS after different complexation time points, and the 
representative LDI mass spectra of MMNP-ChT at different complexation time points 
were shown in Figure 10.5. As shown in Figure 10.2d, the P1 and P2 values measured by 
LDI-MS changed over time, which is consistent with a reorganization of the monolayer. 
The P1 value increased from 0.6 to 0.8, while the P2 value decreased from 0.4 to 0.2 after 
complexation for 24 h at 4 °C (Figure 10.2d). These results suggest that the positively 
charged surface of ChT induces migration of the anionic TCOOH ligand on the MMNP 
surface to maximize the enthalpic interactions of the MMNP and ChT. In other words, the 
monolayer was templated due to protein surface recognition (Figure 10.2b). Moreover, 
the increased complexation time caused a higher degree of monolayer templation, which 
is consistent with the idea that the monolayer requires time to reorganize. In addition, 
MMNPs were incubated with different amounts of ChT to investigate the dose 
dependence of the templation on MMNP monolayers, where no aggregation was 
observed in the MMNP-ChT complexes at different binding ratios. As shown in Figure 
10.2e, using a lower ratio of ChT to MMNP resulted in a smaller change in P1 and thus 
fewer NPs with templated monolayers. As a control, the P1 and P2 values for the MMNPs 
were also measured in the absence of protein, and no obvious change of P1 or P2 was 
observed over a 24 h time period (Figure 10.2f). 
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was 40 µM. The TEM sample of MMNPs was prepared by drop-casting MMNP solution 
onto a 300-mesh nickel grid coated with formvar film. The TEM image of MMNP 
sample was obtained on a JEOL JEM-2000FX transmission electron microscope. DLS 
experiments were performed by using a Malvern Zetasizer (Nano series, Malvern 
Instruments Inc, USA).   
 Gold nanoparticles (AuNPs) protected with 1-pentanethiol (C5), TCOOH and 
TOH ligands were prepared following the reported procedure.18 NPs functionalized with 
TCOOH and TOH mixed-monolayer were prepared following the ligand exchange 
procedure.19 In a typical reaction, 10 mg of C5 functionalized NP (NPC5) was first 
dissolved in 1 mL of dry dichloromethane (DCM). TCOOH and TOH ligands (30 mg of 
TCOOH and 10 mg for TOH) were dissolved in 5 mL of organic solvent (DCM:MeOH 
(4:1 v/v)), and then added to the solution of NPC5. The reaction mixture was stirred at 
room temperature for 3 days. After 3 days, the organic solvent was evaporated and NPs 
were dissolved in MilliQ water. The aqueous solution of the NPs was purified by dialysis 
for 3 days. 
 The LDI-MS analyses were done on a Bruker Autoflex III MALDI-TOF mass 
spectrometer. All mass spectra were acquired in reflectron mode. An average of 200 laser 
shots under 100 Hz frequency was fired to acquire each spectrum. The typical laser 
power was 80%. A 3 μL solution of MMNP-protein complexes in PB was applied to 
target and allowed to air-dry before LDI-MS. Data was analyzed by Bruker software 
(FlexAnalysis Version 3.3) and SAS software. 
 Genetic engineering manipulation and GFP expression were done according to 
previously reported methods.20,21 To construct pQE80-6xHis-GFP plasmid, GFP gene was 
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PCR amplified and cloned from pET21-d EGFP plasmid into BamHI and Hind III 
(downstream of 6xHis tag) restriction sites of pQE80 expression vector. To produce 
recombinant proteins, plasmid containing the respective gene was transformed into 
Escherichia coli BL21(DE3) strain. A transformed colony was picked up to grow small 
cultures in 50 mL 2xYT media at 37 °C for overnight. The following day, 15 mL of 
grown culture was inoculated into one liter 2xYT media and allowed to grow at 37 °C 
until OD reaches 0.6 by using UV-Vis spectroscopy. At this point, GFP expression was 
induced by adding isopropyl-b-D-thiogalactopyranoside (IPTG; 1 mM final 
concentration) at 25 °C. After 16 h of induction, the cells were harvested and the pellets 
were lysed using microfluidizer. His-tagged GFP were purified from the lysed 
supernatant using HisPur cobalt columns. The integrity and the expression of native 
protein were determined by a 12% SDS-PAGE gel and absorbance spectra. GFP was 
cleaved from its His6-tag using thrombinagarose beads (Thrombin CleanCleave™ Kit, 
Sigma-Aldrich) as described in the instruction manual. After the cleavage, GFP was 
passed through a HisPur cobalt column to remove the cleaved His6-tag. Further, the 
residual His6 was removed by a 10 kDa-MWCO (molecular weight cut off) filter. 
 For the salt concentration effect on the monolayer templation, the ChT-MMNP 
complexes was washed with sodium phosphate buffer (5 mM) by using molecular cut off 
filter (Amicon Ultra-0.5 centrifugal filter devices, 3000 MWCO) to reduce the salt 
concentration right before processing the LDI measurement, while the final concentration 
of the MMNP-ChT complexes remained at 5 µM. 
 The ChT activity assay was performed with slight modification to reported 
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